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ABSTRACT
Numerous epidemiology studies demonstrate that acute increases in air pollutants
correlate with an increase in cardiovascular disease-related mortality. The pollutant diesel
exhaust (DE) has been shown to impair both flow-mediated and agonist-induced dilation
of the brachial artery, used as a surrogate for coronary artery function. It is speculated
that enhanced sensitivity to the endogenous vasoconstrictor ET-1 impairs cardiac blood
flow and contributes to the immediate onset of myocardial ischemia and infarction in
humans following DE exposure. In addition, impaired endothelium-dependent dilation
can be improved with the restoration of nitric oxide (NO) synthase (NOS) activity. We
therefore sought to determine the mechanism by which inhalation of DE impairs
coronary artery function by assessing responses to ET-1 and to the endotheliumdependent vasodilator acetylcholine (ACh) in arteries from rats exposed to DE compared
to responses in arteries from rats exposed to filtered air. Given that DE is a source of
reactive oxygen species (ROS) we hypothesized that inhaled DE generates ROS which
uncouples NOS-dependent dilation to augment coronary artery constriction. We observed
augmented vasoconstrictor sensitivity to ET-1 and blunted vasodilator response to ACh
v

in coronary arteries following DE exposure. Interestingly, these alterations in vascular
reactivity appear to result not only from the loss of NO, but also from a gain in NOSderived constrictors. Furthermore, basal activity of NOS was not altered by DE exposure.
Elevated ROS are known to oxidize and deplete tetrahydrobiopterin (BH4) a necessary
cofactor that prevents the uncoupling of NOS. ROS scavenging or BH4 supplementation
prevented the generation of superoxide in isolated arteries as did NOS inhibition. These
treatments also restored dilation to ACh. Therefore, acute inhalation of DE appears to
deplete bioavailable BH4, uncouple NOS and lead to NOS-dependent superoxide
generation. The increased oxidative stress likely scavenges and decreases synthesis of
NO leading to endothelial dysfunction which may contribute to the acute coronary events
initiated by air pollution.
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CHAPTER 1. INTRODUCTION
Air Pollution Causes Cardiovascular Disease
Epidemiological studies have linked air pollution to adverse health effects and
increased cardiovascular morbidity and mortality. Short term exposures exacerbate
cardiovascular and respiratory diseases and increase the incidence of acute myocardial
infarctions (74). Chronic exposures increase the risk of mortality from ischemic heart
disease and heart failure (21). The severity of these trends correlate with the ambient
concentration of fine and ultrafine particulates (diameter <2.5µm and <100nm,
respectively). This is thought to be related to the small size of the ultrafine particles,
which allows them to deposit in all areas of the respiratory tract, including the deep lung.
After deposition, soluble components or even the particles themselves may translocate
across cellular barriers into the bloodstream reaching target organs such as the heart (68).
One study suggests that the biphasic increases in mortality rates following air pollution
exposure are associated with the immediate effects of fine particles and a delayed effect
of the ultrafine particles (40).
Exposure to particulates is of great concern for public health because retention of
certain particles can last up to 70 days in rodents and 700 days in humans (24), which
may promote sustained effects long after exposure. The World Health Organization
estimates 800,000 deaths worldwide are related to inhalation of particulate matter (PM)
(55). According to the Environmental Protection Agency, fine particulates and the
associated gaseous pollutants contribute to 15,000 premature deaths each year in the
United States (95). The most susceptible populations to the effects of air pollution are the
elderly, infants and those with preexisting cardiovascular diseases (77).
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Elevated levels of particulate air pollution correlate with increases in
cardiovascular mortality and hospital admissions for cardiovascular diseases (81-83).
Importantly, particulate pollution rarely occurs alone since emission-source PM is
generated in concert with nitrogen dioxide, carbon monoxide, and volatile organic
compounds.

Additionally, combustion-derived toxicants are added to an ambient

background of other solid and gaseous pollutants. Increased exposure to the gaseous
components of diesel and gasoline engine exhausts (94) also associates with an increase
in cardiac arrhythmias (20; 73; 79) and studies have shown that exposure to air pollutants
increases heart rate (HR) and decreases HR variability (HRV) (78), risk factors for
sudden cardiac failure.
Particulate Matter Deposition and Systemic Translocation
The biological effects of airborne particles depend largely on the site of
deposition. Based on the predictive mathematical model by the International Commission
on Radiological Protection, most particles that enter the respiratory tract deposit in the
nasopharyngeal region. Particles less than 100 nm travel deeper into the lungs, reaching
the tracheobronchial and alveolar regions (68). Deposited particles in the upper regions of
the airway are effectively cleared by the actions of the mucociliary escalator. Cilia lining
the surface of the respiratory tract move debris to the pharynx where it is swallowed (24;
68). Phagocytosis of particulates by alveolar macrophages is the predominate mechanism
of clearance in the alveolar region. These particle-laden macrophages then migrate to the
mucociliary escalator for clearance. However, lung lavage studies have shown
macrophages are inefficient in the clearing of ultrafine particles, recovering
approximately 20% of particles less than 80 nm (46; 66; 67).
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Deposited particles can be leached of hydrophilic elements which are soluble in
both intracellular and extracellular compartments. Absorption, diffusion or protein
binding of these elements permits movement into the systemic circulation. In addition to
absorption of leached elements, epithelial cells may take up intact ultrafine particles
through endocytosis or transcytosis (8) enabling additional systemic translocation.
Ultrafine particles may also move between epithelial cells to reach interstitial sites
permitting access to the lymphatic system and possibly the circulation, although the
movement from the lymphatics to the circulation is hydrodynamically unfavorable (67).
Translocation of particles and their components into the systemic circulation would allow
direct interaction with the distal cardiovascular system, providing a potential mechanism
for air pollutants to initiate cardiovascular events, along with the direct actions of soluble
gases such as CO and NO (71; 101).
Diesel Exhaust has Significant Cardiovascular Effects
The worldwide use of diesel engines in both road and non-road machinery and
vehicles contributes substantially to current air pollution and health problems. DE is
composed of particulate and gaseous phases, both exerting unique adverse health effects.
The more studied particulates are composed of a carbon core with adsorbed sulfates,
nitrates, organic compounds, and metals (94). Diesel engines emit 30 to 100 times more
particulates than gasoline engines with up to 80% of DE particulates ultrafine in size. In
the US Mid-Atlantic region, approximately 20% of particulates in urban air arise from
diesel combustion (94). In 2000, Pope showed that a 10 µg PM/m3 increase was
associated with greater risk of cardiovascular mortality; interestingly, PM exposures did
not associate with increased risk of respiratory mortality (77). Following elevated PM
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exposure, there was a PM association with both an immediate (2 hours) and delayed (2
days) risk of myocardial infarction (19) suggesting there are multiple mechanisms of air
pollution-related deaths.
Animal models also exhibit cardiovascular responses to DE and its components
that are similar to those reported in humans. In spontaneously hypertensive rats
instrumented to record electrocardiograms, DE exposure elevated HR and prolonged PQ
intervals, two markers of ventricular arrhythmias (13). Modest DE exposure also
decreased HRV, a measure of autonomic control, in both control and chronic heart failure
rats but caused ventricular proarrythmias only in rats with chronic heart failure (5)
suggesting pre-existing cardiovascular disease increases susceptibility. Men with
coronary artery disease were also found to develop a greater electrocardiographic ST
depression during exercise with DE exposure, indicative of greater myocardial ischemia.
Furthermore, an elderly population without preexisting cardiovascular conditions
exhibited a reduction in HRV with acute exposure to air pollutants (1) that was absent in
young healthy volunteers (18). These findings suggest an imbalance in parasympathetic
and sympathetic regulation of the electrical control of the heart may be a risk factor for
cardiac arrhythmias and sudden cardiac death.
In addition to hemodynamic changes, inhalation of DE in healthy human
volunteers

enhanced

resting

vascular

tone

and

diminished

agonist-mediated

vasodilatation of the brachial artery in manner persistent at least up to 24 h post exposure
(58; 72; 93). Infusion of endothelin (ET)-1 after this exposure elicited vasoconstriction
only in the DE exposed group. Although plasma ET-1 levels were not altered with DE
exposure, ETB receptor-mediated dilation was impaired suggesting a shift to a more
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constrictive and less dilatory state (52). Similarly, aortic rings from mice exposed to DE
particles (DEP) had impaired endothelium-dependent vasodilation to ACh (35). The ET-1
constrictor response was found to be enhanced following DE inhalation in various
vascular beds (12; 45), suggesting the pollutant has global cardiovascular effects. Thus it
is clear that DE adversely affects cardiovascular health and increases the incidence of
cardiac events, but little is known about the mechanism underlying these effects.
Coronary Artery Biology
Contributing to less than 1% of the total body mass, the heart utilizes
approximately 5% of resting cardiac output and the coronary arteries provide oxygenated
blood to the heart tissues. Unlike skeletal muscles, the heart is metabolically very active
at rest, consuming up to 20 times more oxygen per mass than skeletal muscle for energy
production. To meet the demand for oxygen consumption, 70-80% of the delivered
oxygen is extracted from the blood. Therefore increases in oxygen demand above resting
conditions (i.e. exercise) must be primarily facilitated by increasing coronary blood flow.
Epicardial coronary arteries are low resistance conduit arteries and contribute
little to the regulation of cardiac blood flow. The coronary microcirculation is responsible
for the majority of resistance and blood flow regulation. Endothelium-dependent dilation
primarily regulates vascular tone in coronary arterioles, 40 – 200 m in diameter (50).
The inherit ability of vascular smooth muscle to respond to changes in intraluminal
pressure, myogenic tone, is the primary regulator of tone in the microvessels with
increases in pressure causing vasoconstriction and falls in pressure leading to relaxation
of the vascular smooth muscle (48). The smallest of coronary arterioles are regulated
predominately by metabolic activity (49) whereby increases in metabolic demand cause
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dilation of these smallest arteries to decrease pressure upstream. Myogenic dilation of the
upstream microvessels will further increase flow through the arterioles (41). This
mechanism of coronary vasculature autoregulation ensures blood flow matches cardiac
tissue metabolic demands and buffers it from the primary regulators of the systemic
circulation, sympathetic nervous system activity and circulating hormone agonists. This
is beneficial for the heart which must be oxygenated throughout systole to provide the
nutrients for the active myocardial contraction.
Many vasoactive agents produced in the endothelium modulate coronary vascular
tone in the coronary artery bed. Pharmacological inhibition of endothelium-derived nitric
oxide (NO) has been reported to reduce coronary blood flow in isolated, perfused rat
hearts. This inhibition can be competitively reversed with L-arginine supplementation, a
substrate for NO generation, suggesting this vasodilator is involved in the regulation of
basal tone (9). Endogenous endothelium-derived vasoconstrictors such as ET-1 also
regulate vasomotor tone. Infusion of an ETA receptor antagonist in the left coronary
artery dilated distal coronary arteries with a corresponding increase in coronary blood
flow (56).
Autonomic innervation provides an additional mechanism of coronary vascular
regulation. Sympathetic activation causes constriction of the microvessel mediated by α1adrenergic receptors without affecting coronary arteriole and epicardial artery tone.
Hypoperfusion of the coronary circulation revealed α2-adrenergic receptor mediated
constriction that is absent under basal, normoxic conditions (14). Vasodilation of the
coronary artery from the activation of β-adrenergic receptors modulates the α-adrenergic
receptor mediated constriction. Both β1- and β2-adrenergic receptors are found in the
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coronary vasculature with greater expression of β1-adrenergic receptors in larger and β2adrenergic receptors in small, resistance arteries (63; 96). The heterogeneous distribution
of adrenergic receptors throughout the coronary vasculature results in differential
responses to autonomic nervous system activation to protect the larger arteries from
constriction during systole which would limit delivery of nutrients to the myocardial
muscle.
Therefore, dysregulation of endothelium-derived vasoactive agents or increases in
sympathetic outflow can compromise control of coronary artery tone and blood flow. The
loss of endothelium-derived dilators would have the biggest impact in the small arteries
where a large portion of vascular resistance to flow is generated. It was this size of artery
that we studied. In these arteries, an imbalance toward a constricted state would reduce
oxygen delivery downstream to the small arterioles and a severe imbalance would lead to
prolonged ischemia of all downstream tissues with subsequent necrosis of the
myocardium resulting in myocardial infarction.
Coronary dysfunction
It was estimated in 2006 that more than 17.5 million people have coronary artery
disease (CAD), the single leading cause of death for both men and women in the United
States (4; 105) CAD is the buildup of plaque in the coronary arteries thereby occluding
the vessel and limiting blood flow to cardiac tissues. Long term exposure to concentrated
ambient particles (~15 µg PM/m3) have been demonstrated to accelerate atherosclerotic
plaque development in apoE-/- mice and impair aortic vascular function (87). Decreased
oxygen delivery in the face of various physiological challenges that demand an increase
in cardiac workload will lead to cardiac ischemia, angina and eventual myocardial
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infarction. The increase in vascular resistance in hypertension can exacerbate the effects
of CAD by increasing the workload of the heart. Angiotensin-converting enzymes
inhibitors are commonly used for the treatment of hypertension and have been suggested
to improve CAD patient outcome by decreasing blood pressure (25; 26).
Myocardial infarction from insufficient oxygen delivery to cardiac tissues leads to
myocyte necrosis and initiates localized inflammatory responses at the infarct zone. This
initiates a cascade of events leading to the remodeling of ventricles, most notably left
ventricular hypertrophy (88). The change in ventricular structure is associated with loss
of function from decreased elasticity and compression of coronary arteries (32).
Therefore CAD may accelerate the progression of heart failure. In support, heart failure
patients with CAD with a history of coronary artery bypass graft surgery have decreased
mortality rates from heart failure (31).
Endothelial Cell Function
The single layer of endothelial cells lining the luminal side of the microvascular
system was classically thought to function as a physical barrier separating the blood from
the surrounding tissues. Since the 1980s, however, when Furchgott and Zawadzki
demonstrated that the endothelium is also a source of vasoactive agents (30), numerous
studies have shown the importance of the endothelium in regulating platelet aggregation,
leukocyte adherence, vascular smooth muscle proliferation and several other functions (3;
47; 65). Release of various endothelium-derived vasoactive agents such as NO,
prostacyclin, endothelium-derived hyperpolarizing factors and endothelin-1 help regulate
vascular smooth muscle tone to maintain cardiovascular homeostasis.
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Nitric Oxide
All three isoforms of NOS--neuronal, inducible and endothelial--have been identified in
the vascular system. Neuronal (nNOS) and endothelial (eNOS) isoforms are low output
enzymes mainly expressed in neurons and endothelium, respectively. The inducible
(iNOS) form of NOS can be found in almost any cell type after certain insults and, when
activated, is a high output NO generating enzyme. All three isoforms of NOS are
similarly homodimers with each monomer containing nicotinamide adenine dinucleotide
phosphate (NADPH), flavin adenine dinucleotide (FAD) and flavin mononucleotide
(FMN) binding sites on the C-terminal reductase domain (figure 1). The oxygenase
domain has binding sites for heme, (6R)-5,6,7,8-tetrahydrobiopterin (BH4) and the
substrate L-arginine that are linked to the reductase domain by a calmodulin binding
domain. Stable NOS dimers are formed in the presence of heme and Zn, allowing
interaction between the reductase and oxygenase domains of opposite monomers (2; 29;
62).
Functional eNOS requires sufficient amounts of the substrate L-arginine and the
cofactor BH4 for the production of NO. BH4 is thought to stabilize the physical and/or
electrochemical coupling of the NOS dimer and is generated from GTP through a de novo
pathway mediated by GTP cyclohydrolase or recycled from the oxidized form of BH4,
7,8-dihydrobiopterin (BH2), by dihydrofolate reductase (86). Depletion of BH4 or
increases in BH2 electrochemically uncouple eNOS, resulting in the generation of
superoxide anion radical (O2·-) rather than NO (15; 86). In a cascade fashion,
peroxynitrite (ONOO-) production from the reaction of O2·- and NO not only depletes
bioavailable NO but can also oxidize BH4 to catalyze further eNOS uncoupling.
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Figure 1: NOS dependent synthesis of NO and O2-. Nicotinamide adenine
dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin
mononucleotide (FMN), calmodulin binding domain (CAM), L-arginine (Arg),
tetrahydrobiopterin (BH4). Adapted from Munzel et al. Arterioscler Thromb Vasc
Biol. 2005
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The generation of NO and L-citrulline from L-arginine and O2 starts with flavinmediated NADPH electron transfer to the heme center, activating O2. Two separate
oxidation steps are required to generate NO and L-citrulline from the intermediate Nωhydroxy-L-arginine. Both intracellular calcium levels and phosphorylation states
modulate eNOS activity. Increases in intracellular calcium allow binding of calmodulin
to its domain in eNOS to facilitate efficient NO synthesis (84). Additionally, eNOS
activity can be enhanced by phosphorylation at S1179 by calmodulin kinase II or
inhibited by PKC phosphorylation of T497.
NO diffuses to the nearby vascular smooth muscle cells and other tissues where
its primary functions are mediated by binding the heme iron of soluble guanylate cyclase.
The heterodimeric soluble guanylate cyclase (1α and 1β subunit) catalyzes the production
of cyclic GMP (cGMP) from GTP to have varying effects depending on cell type.
Stimulation of soluble guanylate cyclase can lead to phosphorylation of the inositol
triphosphate receptor by cGMP-dependent kinase to inhibit Ca2+ efflux into the cytosol
from the sarcoplasmic reticulum. Additionally, cGMP-dependent kinase-dependent
phosphorylation increases the open probability of the large conductance Ca2+-activated
K+ channels (BKCa), reducing Ca2+ influx by hyperpolarizing the smooth muscle cell
(62). The reduction in smooth muscle intracellular calcium in turn decreases contraction
allowing vasodilation.
Cyclooxygenase
Although encoded by distinct genes, the two isoforms of cyclooxygenase (COX)
are structurally and functionally similar (22). COX catalyzes the conversion of
arachidonic acid liberated from cellular phospholipids by phospholipase A2 (PLA2) to
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prostaglandin H2 (PGH)2, by action of specific synthases or isomerases, is further
converted to the prostanoids PGD2, PGE2, PGF2, PGI2 (prostacyclin), or TXA2
(thromboxane A2) (97). COX-1 is constitutively expressed in most mammalian cell types.
COX-3, sometimes known as COX-1b or COX-1 variant, is a splice variant of COX-1
where intron one is retained, causing a reduced enzymatic activity compared to COX-1 or
COX-2. COX-2 expression is regulated and induced by endogenous stimuli such as
cytokines and growth factors. COX-2 is undetectable in most cell types except rodent
brain and kidneys, where it is constitutively expressed (22; 44; 97).
Regulation of the two COX isoforms is quite different. The inducibility of COX-2
is attributed to the various response elements in the promoter and enhancer regions.
Namely, the cAMP response element in the promoter region is an essential regulation site
of COX-2 responding to both cAM-dependent and independent factors (i.e. c-fos, c-jun
homo-/heteromers) (44). Although classically considered an inducible isoform, recent
studies show the involvement of constitutive COX-2 in various organ system functions
such as renal, brain and nervous system (22).
The rate limiting step in prostanoid production is the COX enzyme oxidation of
arachidonate and under normal physiological conditions is dependent on COX-1. In the
vascular endothelium, the vasodilator PGI2 is the predominant prostanoid product, up to
eight fold higher than other prostanoids (22; 64). PGI2 binds to its G-protein (Gs) coupled
receptor (IP) on the vascular smooth muscle to increase cAMP leading to vasodilation. IP
receptor activation also has been shown to inhibit proliferation of vascular smooth muscle
cells. Altered expression of VEGF and Zn finger transcription factors, along with 81
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other genes was detected by microarray analysis following IP receptor stimulation of
human pulmonary artery vascular smooth muscle cells with iloprost, a PGI2 analog (64).
Endothelium-Derived Hyperpolarizing Factors
The liberation of arachidonic acid from cellular phospholipids by PLA2 also
provides substrate for the cytochrome P450 to produce epoxyeicosatrienoic acids (EETs).
Four regioisomeric EETs (14,15-, 11,12-, 8,9-, and 5,6-EETs) are synthesized by the
endothelium. However 14,15- and 11,12-EETs are the major metabolites. Vascular
smooth muscle cells can metabolize arachidonic acid but to a lesser degree, and
production of EETs was not detected in bovine coronary artery smooth muscle cells (11).
EETs have been described as endothelium-derived hyperpolarizing factors,
vasodilator compounds that do not including NO and prostacyclin and which activate
potassium channels to hyperpolarize and therefore relax vascular smooth muscle cells.
Concentration-dependent arachidonic acid-mediated dilation of bovine coronary artery
was abolished with endothelium removal, suggesting that arachidonate is converted in the
endothelium to one or more vasoactive products. In the presence of COX inhibition,
cytochrome P450 inhibition blocked arachidonate-mediated dilation completely.
Furthermore, the dilatory effects of exogenous EETs were inhibited by elevating
extracellular K+ or by blocking calcium activated K+ channels (KCa). When smooth
muscle membrane potential was measured following 11,12-EET application, an
iberiotoxin-sensitive hyperpolarization was observed, suggesting that EETs mediate
relaxation by activating large conductance KCa (BKCa) to hyperpolarize the smooth
muscle and decrease Ca2+ influx through voltage sensitive Ca2+ channels (11; 28).
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Recent studies with selective EET agonists and antagonists indicate that EETs are
diffusible factors interacting with G-protein coupled receptors. Downstream effects of
EETs are inhibited by anti-Gsα, but not anti-Gsβγ or anti-Giα, antibodies (11). KCa
channel activity may be regulated by cAMP through activation of protein kinase A and
11,12-EET has also been implicated in the activation of protein kinase A (28). Evidence
that receptors mediate the actions of EETs come from studies of silica bead bound EETs
that prevent crossing cellular membrane, but that do not inhibit downstream activities. In
monocytes and human leukemic monocyte lymphoma cell lines, 3H-14,15-labeled EET
exhibited high affinity saturable binding that was noncompetitive with other eicosanoids
and fatty acids (11). These data suggest receptors mediate the actions of EETs although
the receptors have yet to be identified.
The attenuation of EET mediated relaxation by endothelium removal could be
indicative of either endothelial production or that the endothelium is the site of action
(100). In endothelial cells, EETs have been shown to activate the non-selective cation
channel, transient receptor potential (TRP) channels, in a autocrine manner to increase
Ca2+influx (98). In endothelial cells, this increase in intracellular Ca2+ not only increases
NOS and COX activity, but also activates endothelial small (SKCa) and intermediate
(IKCa) conductance KCa to cause membrane hyperpolarization. (75). Endothelial
hyperpolarization can be conducted to the vascular smooth muscle through gap junction
to further cause relaxation (80). Inhibition of EET synthesis has been demonstrated to
inhibit conducted hyperpolarization of the vascular smooth muscle (23; 27). Taken
together, these studies suggest EETs regulate vascular tone through effects on both
endothelium and vascular smooth muscle.
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Endothelins
ETs are synthesized as prepro-hormones that are enzymatically cleaved twice by
the endothelin converting enzyme (ECE) to form active 21 amino acid peptides. The
three isoforms, ET-1, -2, -3 are each encoded by different genes and possess autocrine,
paracrine and endocrine activity. Vascular endothelial cells are the main site of ET-1
synthesis and can also produce ET-2 but not ET-3. Both ET-1 and ET-2 are additionally
generated in the heart, kidney and central nervous system. Endocrine, gastrointestinal and
central nervous system cells have been found to express ET-3 (16). ET-1 can be
immediately released or stored in Weilbel-Palade bodies, which upon stimulation fuse
with the plasma membrane to release their contents into the myoendothelial cleft (39).
ET-1 is the most potent vasoconstrictor of the three isoforms, followed by ET-2
and ET-3 which also has vasodilator properties. ETs bind to ET receptors A and B (ETAR
and ETBR, respectively), which are found on vascular endothelial cells and smooth
muscle cells (figure 2). These two G protein coupled receptors activate phospholipase C,
which increases intracellular calcium via generation of inositol 1,4,5-trisphosphate (IP3)
and accumulation of 1,2-diacylglycerol (16). ETBR located on the surface of endothelial
cells function to clear ET from plasma and to stimulate vasodilator generation to help
regulate vascular tone (36; 39). Endothelial vasodilators that can be increased by ET-1
activation of ETB-receptors include NO, COX products, and several poorly defined
hyperpolarizing factors. Both receptor subtypes are also found on vascular smooth
muscle cells where activation of either receptor leads to vasoconstriction, mediated in
part by generation of O2·- (53; 99).
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Figure 2: Endothelial and vascular smooth muscle effects of ET-1. L-citrulline (Cit),
endothelin A and B receptor (ETA/BR).
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Diesel Exhaust Generates Reactive Oxygen Species
One potential factor linking DE to cardiovascular events is an apparent increase in
oxidative stress observed as elevated levels of reactive oxygen species (ROS). ROS can
participate in normal cellular signaling by modifying kinases and phosphatases and
regulating transcription factors (76; 102). Xanthine oxidases, NADPH oxidases,
uncoupled endothelial nitric oxide (NO) synthase (eNOS), and mitochondrial respiration
are endogenous sources of ROS within the vasculature. Cellular defenses against excess
ROS include antioxidants (i.e. glutathione, bilirubin) and scavenging enzymes (i.e.
superoxide dismutase (SOD) and catalase) (104). However, when antioxidant systems are
overwhelmed, excess ROS contributes to the development of atherosclerosis, heart failure
and other cardiovascular diseases by reacting with proteins, sugars and lipids to alter the
function of these targets (54; 104).
Chemicals found in DE and other air pollutants may spontaneously release ROS
in tissues and cultured cells and to potentially stimulate endogenous ROS generating
enzymes. In situ measurements in hearts and lungs from rats exposed to air pollutants
showed cumulative increases in ROS accompanied by mild tissue damage, edema and
activation of antioxidant pathways (33). DEP and organic extracts from DEP also dosedependently increase hydrogen peroxide generation in human airway epithelial cell lines
(7). DEP and whole DE may thus augment ROS generation beyond the antioxidant
capacity, damaging susceptible target tissues.
Endothelin and Reactive Oxygen Species
In addition to tissue damage, ROS in EC can increase production of ET-1.
Angiotensin-II-mediated increases in ET-1 production and blood pressure were prevented
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by an SOD mimetic, tempol, or the antioxidant, vitamin E (70). In addition, exogenous
ROS-induced increases in ET-1 transcripts and protein were inhibited by ROS
scavenging (42; 43). Thus oxidative stress may mediate ET-dependent cellular responses
and induce ET-1 synthesis.
Endothelial Dysfunction and Reactive Oxygen Species
Endothelial cells aid in regulating vascular tone by releasing various vasodilators
such as PGI2, NO and endothelium-derived hyperpolarizing factors as described above.
ROS such as O2- react with NO to form peroxynitrite and reduce NO bioactivity (60). The
antioxidant superoxide dismutase scavenges O2- to prevent the reaction of O2- and NO
(61; 69) and inadequate levels of endogenous superoxide dismutase lead to impaired
endothelium-dependent dilation (104). Another antioxidant pathway induced by oxidative
stress is hemoxygenase-1, which catalyses the degradation of heme to biliverdin (89;
103). Biliverdin is subsequently reduced to bilirubin, a potent antioxidant (85).
Inadequate levels of these endogenous antioxidants can thus diminish NO bioavailability,
further contributing to endothelial dysfunction. Endothelial dysfunction in the coronary
vasculature increases the risk of myocardial and coronary artery diseases (10).
Endothelin and Coronary Function
Elevated levels of ET are associated with endothelial dysfunction and many
cardiovascular disease states including left ventricular hypertrophy and heart failure (6;
38). ETAR is the predominate receptor in the human heart and coronary arteries (17; 37;
59). It binds ET-1 to maintain basal coronary vasomotor tone (51; 57). Compared to
healthy individuals, hypertensive patients have increased ETAR-mediated vasoconstrictor
tone (34) and treatment with the ETAR antagonist BQ-123 prevented endothelial

19

dysfunction to improve coronary circulation (51). Thus, elevated peptide and receptor
expression and/or function could predispose individuals to the negative cardiovascular
sequelae of air pollutants such as DE, which further activate the ET constrictor pathway.

Summary and Hypothesis
Exposure to air pollutants such as DE increases ROS generation in cultured cells
and in animals. Furthermore, DE can increase the synthesis of vasoconstrictor ET
peptides (90-92) and the incidence of cardiac events (19; 82). However, it is unknown if
ROS generation and increased ET levels contribute to the coronary events associated with
DE exposure. Furthermore, it is not known if DE alters coronary artery contractility to
potentially contribute to increased cardiac events. The following studies evaluated the
effect of DE on coronary artery vasoactivity and the underlying mechanisms of the
changes to determine if ROS generation with subsequent endothelial dysfunction
contributes to negative cardiac consequences of DE inhalation. The following specific
aims addressed our hypothesis that inhaled DE generates ROS to augment coronary
artery constriction (figure 3).
Specific Aim 1: Determine the effect of inhaled DE on coronary artery contractility.
Specific Aim 2: Determine how DE-induced ROS production affects coronary artery
contractility.
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Figure 3: Overall hypothesis.
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CHAPTER 2. EXPERIMENTAL METHODS
Diesel Exhaust Exposure
Diesel exhaust was produced from a single-cylinder, 5500-watt, Yanmar dieselengine generator using nationally certified diesel fuel at the Lovelace Respiratory
Research Institute facility. Electrical current was drained from the engine to provide a
constant load (90%) during operation. Desired PM concentrations were attained by
diluting the direct exhaust with filtered air. Exposure chamber temperature and humidity
were monitored throughout exposures, and temperatures were maintained in the range of
20–25° C. The particle concentration was monitored by sampling on 47-mm Pallflex
(Pall-Gelman) filters. Pre-filter and post-filter weights were measured by a Mettler MT5
microbalance with static discharged before weighing to avoid any interference from
electrical charge on the filters. Filter samples were collected two times a day (every 3 h)
for each DE exposure chamber; one filter sample per day was collected from the control
chamber.
Male Sprague-Dawley rats (250-300 g) were exposed to DE by placement in a
sealed chamber to maintain a 300 g/m3 DE exposure concentration. This exposure has
been previously shown not to cause pulmonary inflammation (5) and reflects 24 h limits
of PM set by the Environmental Protection Agency. Control rats were housed in the same
chamber but exposed only to filtered air. Rats were housed in identical cages under the
same light-dark cycle.
Mean Arterial Pressure
Rats were instrumented with telemetry devices as instructed by the manufacturer
(Data Sciences Instruments, Minneapolis, MN) to record mean arterial pressure (MAP),
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HR and electrocardiograms (ECG). After one week surgical recovery, rats were exposed
to either filtered air or DE as described above.
Heart Rate Variability
The clinical relevance of HRV as a prognostic tool for adverse cardiovascular
outcome in various disease states was first realized in the 1960s (4). HRV, in its simplest
definition, is the variance between successive heart beats. The intrinsic pacemaker
property of the sinoatrial node maintains a relatively constant HR in the absence of
extrinsic intervention. However, the heart is under continuous control of the autonomic
nervous system to respond to ever-changing environmental stimuli by constantly
adjusting HR and contractility of cardiac muscles. Parasympathetic modulation of heart
rate is mediate by release of acetylcholine (ACh). The effects of parasympathetic
influence are brief as the high concentration of cholinesterase present in the sinoatrial
node degrades ACh rapidly, thus higher frequency HR changes are associated with
parasympathetic activity (6). Contrary, lower frequency HR variations are linked to
sympathetic responses mediated by the slower catabolism of epinephrine and
norepinephrine (1). The inability to respond to the changing demand on the heart
(diminished HRV) may signify cardiac dysfunction.
RR interval (RRI, msec/beat), the time interval between heart beats, was extracted
from ECG recordings from radiotelemetery implanted rats. RRI series were broken into
15 min intervals and transformed using custom software as previously described (3). The
low frequency (LF) variability range, representing a composite of sympathetic nervous
system activity (SNSA) and parasympathetic nervous system activity (PSNSA), was set
at 0.2–1.2 Hz, while the high frequency variability (HF) range, representative of PSNSA,
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was set at 1.2–4.0 Hz. Sympathetic heart rate variability, expressed as the ratio of LF/HF
of transformed RR intervals, was used as an index of SNSA. HR was calculated from the
recorded RRI (1 min/RRI = HR, BPM) or from telemetry recordings.
Isolated Artery Preparation
Intraseptal coronary arteries with an average inner diameter of 200 ± 2 µm were
isolated within 30 minutes following the end of exposure and placed in chilled
physiological saline solution (PSS); ([in mM] 129.8 NaCl, 5.4 KCl, 0.83 MgSO4, 19
NaHCO3, 1.8 CaCl2, and 5.5 glucose). Each of the two open ends of the arteries were
cannulated onto glass micropipettes in a tissue chamber (Living Systems, CH-1) and
secured with silk sutures. Tissue chambers were placed on the stage of an inverted Nikon
Eclipse TS 100 microscope fitted with a video camera connected to a computer. Inner
diameter changes were recorded using edge detection software (IonOptix). Decreases in
measured diameter represent constriction of the artery while increases in diameter reflect
dilation of the artery.
Vessels were stretched to approximate in situ length and pressurized to 60 mmHg
with PSS in the lumen absent of flow and superfused at a rate of 5 mL/min with 37oC
oxygenated (21%) PSS. Prior to the start of an experiment, vessels were equilibrated for
45 minutes at 37 oC with recirculated superfused PSS. Spontaneous or myogenic tone
would develop in these arteries during the time of equilibration. At the end of the
experiment, Ca2+ free PSS was superfused for 60 minutes to fully relax the vessel. The
endothelium was disrupted in some experiments to directly assess VSM function without
the presence of endothelial influences. The endothelium was disrupted by inserting a
strand of moose mane fiber into the free distal end of the vessel. Any loose EC were then
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flushed from the vessel before cannulating the distal end and securing it with silk sutures.
Endothelial inactivation was verified by the lack of a dilator response to ACh and a
maintained constrictor response to the thromboxane mimetic agonist, U-46619 (2).
Contractile Studies
Arteries were treated with and without inhibitors of NOS (L-NNA, 100 µM) in
the superfusate and in the lumen for at least 30 minutes prior to the start of the
experiment during equilibration to assess the role of endothelium-derived relaxing
factors. The involvement of the endothelin pathway was evaluated with antagonists of the
ETAR (BQ123, 10 µM) and ETBR (BQ788, 10 µM). Treated vessels were then
constricted with increasing concentrations of ET-1 (0.1 to 10 nM) in the recirculating
superfusate. VSM function was determined in endothelium disrupted arteries and also
with the VSM depolarizing agent KCl (5-90 mM). Percent constriction was expressed as
agonist induced tone.
Dilator Studies
ACh-induced dilation was recorded in cannulated and pressurized, endothelium
intact arteries preconstricted with U46619 (to ~50% of Ca2+-free diameter) to normalize
starting tone between groups. Studies were conducted in the presence or absence of NOS,
COX (indomethacin or aspirin, 10 µM), EDHF and ROS (PEG-SOD, 150 U/mL)
inhibitors as described above. The effects of BH4 depletion was assessed with
supplementation of sepiapterin (1 µM) which through the salvage pathway of BH4
biosynthesis generates BH4. Agonist induced dilation was evaluated using increasing
concentrations of ACh added to the superfusate in 0.5 µM steps. Dilation was recorded as
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percent of Ca2+-free diameter (i.e. 100% = Ca2+-free diameter) determined at the end of
each study. Each artery was used for only one curve.
Quantitative PCR
Freshly isolated coronary arteries were placed in RNAlater (Qiagen) RNA
stablilization reagent overnight at 4oC before long term storage at -80oC. Total RNA was
extracted from coronary arteries using the RNAeasy Fibrous Tissue Mini kit (Qiagen)
and concentration of the elution was determined with a NanoDrop technology instrument
(ND-1000). Reverse transcription was used to generate cDNA, and subsequently real
time PCR for, ET-1, ETAR, ETBR and the endogenous control 18s was performed using
an Applied Biosystems Fast 7500 PCR machine and TaqMan Gene Expression Assays.
Plasma NOx, NE and ET-1
Blood was collected via cardiac puncture from anesthetized rats, chilled on ice and
centrifuged at 1000 rpm within 15 minutes of collection. Aliquots of plasma were frozen
in liquid nitrogen and stored at -80oC. NO released from the endothelium is rapidly
oxidized to nitrite (NO2-) and nitrate (NO3-). Plasma NOx (sum of NO2- and NO3-) is a
crude measure of NO release. Total NOx levels were assayed using a nitrate/nitrite
colorimetric assay (Cayman Chemicals) based on the Griess assay. Plasma
norepinephrine (NE) levels were assessed using a commercially available ELISA (BA
10-0200, Rocky Mountain Diagnostics, Inc). Circulating plasma ET-1 peptide was
assayed using chemiluminescent immunoassay (R&D Systems).
Inflammatory Markers
Plasma levels of granulocyte colony-stimulating factor (G-CSF), macrophage
inflammatory protein 1 alpha (MIP-1α), interleukin 1 beta (IL-1β), interleukin 4 (IL-4),
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interleukin 2 (IL-2), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), monocyte
chemotactic protein 1 (MCP-1), interferon-gamma (IFN-γ) and growth-related oncogene
(GRO-KC) were used as markers of inflammation and assayed using Milliplex

MAP

rat

cytokine immunoassay (Millipore).
ROS Detection
Oxidation of the cell permeable fluorescent probe, dihydroethidium (DHE), by
O2- generates ethidium+ which then intercalates into DNA of cells (7; 8). Septum from
both Air and DE exposed animals were embedded in OCT (TissueTek) without fixation
and flash frozen with liquid nitrogen. Septal sections (10 µm) were allowed to dry on
glass slides for 30 minutes at room temperatures proceeded by treatment with PBS,
LNNA (100 µmol/L) or the superoxide dismutase mimetic, tiron (10 µmol/L) for 30
minutes at 37ºC followed by incubation with DHE (10 µmol/L) with inhibitors for 45
minutes at 37ºC. Coverslips were mounted on each slide with Vectashield. Images of
coronary arteries were captured on a Nikon Optiphot fluorescence microscope using a
Chroma TRITC filter set (excitation: 510-560 nm; emission: 570-650 nm). Data were
expressed as average intensity (integrated intensity per area of region of interest) from
one artery per rat for four rats in each group using Metamorph software (v7.0).
Statistical Analysis
Change in coronary contractility was compared between treatments and groups
using two-way ANOVA for all protocols. If this test revealed differences, the StudentNewman-Keuls post hoc test was performed to make pairwise comparisons. p values
≤0.05 were accepted as statistically significant.
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Calculations
Active tone (myogenic or drug-induced) and agonist induced dilation is calculated as
the percent change in inner diameter as shown below.

Myogenic tone:

Diameter (-Ca2+ ) – Diameter (+Ca2+ )
Diameter (-Ca2+ )

–

Percent constriction:

Percent dilation:

* 100

–

* 100

%
%

* 100
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CHAPTER 3
Specific Aim 1: Determine the effect of inhaled DE on coronary artery contractility
Hypothesis: DE acutely augments coronary artery vasoreactivity via ET receptormediated pathways.
Rationale: Contrary to our hypothesis, autonomic balance was not different between
groups with DE inhalation (see appendix). However, the normal diurnal fall in MAP was
absent in rats exposed to DE and DE appeared to augment expression of several
components of the endothelin system. The lack of change in sympathetic activity indices
and heart rate with a relative elevation in MAP suggested vascular resistance mediated by
endothelin constriction may have been increased by DE exposure to maintain arterial
pressure. However, systemic changes are minimal and the majority of the morbidity
changes in epidemiological studies suggest the heart is the primary target. Therefore
future studies focused on the effects of endothelin in coronary arteries.
Endothelins contributes significantly to coronary vascular tone through actions at
both ETA and ETB receptors. Endothelin-mediated increases in coronary vascular
resistance can result from enhanced coronary artery constriction through activation of the
vascular smooth muscle ETA and ETB receptors and diminished release of endothelium
dependent vasodilators mediated by endothelial ETB receptors. Therefore the following
study evaluated coronary reactivity to endothelin. Because previous work had found that
inhalation of DE causes NOS mediated endothelial dysfunction in both humans and
animals, we investigated basal and ET-1-activated NOS modulation of coronary artery
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function following DE exposure. We hypothesized that DE acutely augments coronary
artery vasoconstrictor reactivity via ET receptor-mediated pathways.
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Abstract
Air pollutant levels positively correlate with increases in both acute and chronic
cardiovascular disease. The pollutant diesel exhaust (DE) increases endothelin (ET)
levels, suggesting this peptide may contribute to DE-induced cardiovascular disease. We
hypothesized that acute exposure to DE also enhances ET-1-meditated coronary artery
constrictor sensitivity. Constrictor responses to KCl, U46619, and ET-1 were recorded
using video microscopy in pressurized intraseptal coronary arteries from rats exposed for
5 h to DE (300 μg/m3) or filtered air (AIR). ET-1 constriction was augmented in arteries
from DE-exposed rats. Nitric oxide synthase (NOS) inhibition (N-nitro-L-arginine, LNNA, 100μM) and endothelium inactivation augmented ET-1 responses in arteries from
AIR but not DE rats so that after either treatment, responses between groups were not
different. DE exposure did not affect KCl and U46619 constrictor responses while NOS
inhibition equally augmented KCl constriction in both groups. Thus basal NOS activity
does not appear to be affected by DE exposure. The ETB receptor antagonist BQ-788 (10
µM) inhibited ET-1 constriction in DE but not AIR arteries and constriction in the
presence of the antagonist was not different between groups. Cytokines levels were not
different in plasma from DE and AIR rats suggesting acute exposure to DE does not
cause an immediate inflammatory response. In summary, a 5-h DE exposure selectively
increases constrictor sensitivity to ET-1. This augmentation is endothelium-, NOS- and
ETB receptor-dependent. These data suggest DE exposure diminishes ETB receptor
activation of endothelial NOS and augments ETB-dependent vasoconstriction. This
augmented coronary vasoreactivity to ET-1 following DE, coupled with previous reports
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that DE-induces production of ET-1, suggests that ET-1 may contribute to the increased
incidence of cardiac events during acute increases in air pollution levels.
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Introduction
Epidemiological studies have linked air pollution to an increased incidence of
cardiovascular morbidity and mortality (23; 38; 39; 44; 48). Short-term exposures
exacerbate cardiovascular and respiratory diseases and may induce acute myocardial
infarction in susceptible individuals (37). Recently, several reports have noted a strong
association between traffic exposure and cardiac outcomes (19; 40), suggesting vehicular
pollutants influence cardiovascular health.
The worldwide use of diesel engines in road and non-road machinery and in
passenger vehicles contributes substantially to ambient air pollution and, potentially, to
associated health problems. Indeed, previous studies have shown that inhaled diesel
exhaust (DE) adversely affects cardiovascular parameters (31; 35; 45), but little is known
about the mechanism underlying these affects. DE is a complex mixture of particulate
and gaseous phases, both of which exert unique adverse health effects. Diesel engines
emit 30 to 100 times more particulates than gasoline engines (46), and the United States
Environmental Protection Agency (EPA) estimates that approximately 20% of
particulates in urban air in the U.S. Mid-Atlantic region originates from DE (47). This
particulate phase has been associated with direct vasoconstrictor effects (27),
exacerbation of atherosclerosis (2), and inhibition of endothelial function (16; 42). In
addition, DE contains gaseous compounds including nitrogen oxides (NOx), CO, and
volatile organics that are also associated with arrhythmias and adverse cardiac events (9;
36; 40).
Metabolic changes associated with DE exposure include increased plasma
endothelin (ET) (28; 35) that has been associated with many cardiovascular disease states
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including heart failure and left ventricular hypertrophy (3; 21). In human heart and
coronary arteries, endothelin A receptor (ETAR) is the predominant ET receptor (8; 20;
33) and its activation by ET potently stimulates both cardiac hypertrophy and
vasoconstriction (26; 29). Compared with healthy individuals, hypertensive patients (15)
and coronary bypass patients (26) have increased ETAR-mediated vasoconstrictor tone.
Although smooth muscle cell endothelin B receptors (ETBRs) can contribute to
vasoconstriction in some vascular beds (17; 24), their primary contribution to vascular
tone in the coronary circulation is not well characterized. In contrast, endothelial ETBRs
have beneficial effects on the vascular wall by clearing ET from plasma and by
stimulating generation of the vasodilator nitric oxide (NO) (18; 22). Thus, elevated
receptor expression and/or function could predispose individuals to the negative
cardiovascular sequelae of DE, which appears to activate the ET constrictor pathway
(28).
We have previously shown diesel exhaust exposed rats maintained a higher heart
rate and displayed markers of ventricular arrhythmias (7). Furthermore, exposure of
isolated murine coronary arteries to diesel emissions augments vasoconstriction (6);
however, the effect of inhaled diesel emissions and the underlying biological mechanisms
for such effects remain unknown. Thus, the present study exposed healthy rats to inhaled
DE to test the hypothesis that DE acutely augments coronary artery vasoreactivity via ET
receptor-mediated pathways.
Methods
Animals: All animal protocols were reviewed and approved by the Institutional
Animal Care and Use Committee of the Lovelace Respiratory Research Institute (LRRI)
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and conform to National Institutes of Health (NIH) guidelines for animal use. Male
Sprague-Dawley rats (250–300 g, Charles River Laboratories) were exposed to 300 g
particulate matter (PM)/m3 DE in a sealed chamber for 5 h. This exposure is
approximately equal to the 24-h limit for PM set by the EPA for humans. The DE system
has been previously characterized and produces levels of CO and NOx at approximately 3
ppm and 4 ppm, respectively (30). Control rats (AIR) were housed identically but
exposed to filtered air. Within chambers, rats were housed in standard cages and
maintained on a 12:12 h light:dark cycle with food and water available ad libitum prior to
exposures. Food was withdrawn during DE exposure.
DE exposure: DE was generated from a single-cylinder, 5500-watt, Yanmar
diesel generator using nationally certified diesel fuel at the LRRI facility. Electrical
current was drained from the engine to provide a constant 90% load during operation to
assure consistent emissions. The particle concentration was monitored by sampling on
47-mm Pallflex (Pall-Gelman) filters. Filters were collected two times a day (every 3
hours) for each DE exposure chamber and once per day from the control chamber. Prefilter and post-filter weights were measured with a microbalance and desired
concentrations of the emissions were attained by diluting the direct exhaust with filtered
air. Exposure chamber temperature and humidity were monitored throughout exposures
and temperatures were maintained at 20–25°C (30).
Isolated artery preparation. At the end of the 5-h exposure, fumes were offgassed for 30 minutes and then the rats euthanized with sodium pentobarbital (200
mg/kg, i.p.). Hearts were immediately removed and intraseptal coronary arteries with an
inner diameters of equivalent size between groups (AIR: 184 ± 8, DE: 187 ± 8 µm) were
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isolated and placed in chilled physiological saline solution (PSS, in mM, 129.8 NaCl, 5.4
KCl, 0.83 MgSO4, 19 NaHCO3, 1.8 CaCl2, and 5.5 glucose) aerated with 21% O2, 6%
CO2 and 73% N2. Each artery was used for only one experimental treatment. Both ends
of the arteries were cannulated onto glass micropipettes in a tissue chamber (Living
Systems, CH-1) and secured with silk sutures within 30 minutes of isolation from the
heart. Vessels were stretched to approximate in situ length and pressurized to 60 mmHg
with PSS in the lumen absent of flow and superfused at a rate of 5 mL/min with 37oC
oxygenated PSS. At the end of the experiment, Ca2+-free PSS was superfused for 60 min
to fully relax the vessel. The endothelium was disrupted in some experiments by rubbing
the lumen of the artery with a strand of moose mane inserted into the free distal end of a
vessel attached at the proximal end to a cannula. Loose endothelial cells were then
flushed from the artery before cannulating the distal end and securing it with silk sutures.
Endothelial inactivation was verified by lack of a dilator response to ACh and a
maintained constrictor response to U46619 (5).
Contractile studies. Vessel chambers were placed on the stage of an inverted
Nikon Eclipse TS 100 microscope fitted with a video camera connected to a data
acquisition computer. Inner diameter changes were recorded using edge detection
software (IonOptix) as described previously (10). Arteries were treated for at least 30
minutes with nitric oxide synthase (NOS) inhibitor (N-nitro-L-arginine, L-NNA, 100
μM), ETBR antagonist BQ-788 (10 μM), ETAR antagonist BQ-123 (10 μM), or vehicle in
the superfusate and in the lumen prior to constriction with increasing concentrations of
endothelin-1 (ET-1, 0.1–10 nM), KCl, (10–90 mM), or thromboxane A2 mimetic U46619
(0.1 nM–1 mM), added to the recirculating superfusate.
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Quantitative PCR: Total RNA was extracted from coronary arteries using the
RNeasy Fibrous Tissue Mini Kit (Qiagen). Reverse transcription-generated cDNA (High
Capacity cDNA Reverse Transcription Kit, Applied Biosystems), and real-time PCR for
ETAR, ETBR, and the endogenous control 18s was performed using an Applied
Biosystems’ Fast 7500 PCR machine and TaqMan Gene Expression Assays. Data
expressed as relative change from AIR group.
Plasma NOx, ET-1 and inflammatory response: Blood was collected via cardiac
puncture from anesthetized rats, chilled on ice, and centrifuged at 1000 rpm within 15
min of collection. Aliquots of plasma were frozen in liquid nitrogen and stored at -80oC.
NO released from the endothelium is rapidly oxidized to nitrite (NO2-) and nitrate (NO3-)
so that a change in plasma NOx (sum of NO2- and NO3-) is a crude measure of NO
release. Total NOx levels were assayed using a nitrate/nitrite colorimetric assay (Cayman
Chemical) based on the Griess assay. Circulating plasma ET-1 peptide was assayed using
chemiluminescent immunoassay (R&D Systems). Plasma levels of granulocyte colonystimulating factor (G-CSF), macrophage inflammatory protein 1 alpha (MIP-1α),
interleukin 1 beta (IL-1β), interleukin 4 (IL-4), interleukin 2 (IL-2), interleukin 6 (IL-6),
tumor necrosis factor alpha (TNF-α), monocyte chemotactic protein 1 (MCP-1),
interferon-gamma (IFN-γ) and growth-related oncogene (GRO-KC) were used as
markers of inflammation and assayed using Milliplex

MAP

rat cytokine immunoassay

(Millipore).
Statistical analysis and calculations: Constrictor responses were analyzed using
two-way repeated-measures ANOVA with Student-Newman-Keuls post hoc analysis for
differences between groups, concentrations, and interactions. Differences in ET receptor
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mRNA, plasma NOx, and ET-1 between groups were analyzed by Student’s t-test. P <
0.05 was considered statistically significant for all analyses. Active tone (myogenic or
drug-induced) is calculated as the percent change in inner diameter as shown below.
Myogenic tone:

–

Percent constriction:

* 100
–

* 100

Results
DE augments endothelium-dependent ET-1 constriction. Coronary arteries from
rats exposed to DE had enhanced vasoconstrictor responses to ET-1 compared with
arteries from air-exposed rats (Figure 1A, p < 0.001). Maximal constriction was greater in
the DE group compared to AIR (80 ± 7% versus 49 ± 7, p < 0.001). The inner diameter of
fully relaxed (Ca2+- free PSS) coronary arteries was not different between AIR and DEexposed animals (167 ± 9 versus 191 ± 21 µm, respectively). ET-1 vasoconstriction was
augmented only in the AIR group by inactivating the endothelium and the response was
not different between groups in endothelial disrupted arteries (Figure 1B). Maximal
constriction following endothelial inactivation was 74 ± 4 versus 72 ± 5% in AIR and DE
arteries respectively (p = 0.687).
KCl-mediated constriction unchanged following DE. Receptor-independent
vasoconstriction was assessed by increasing extracellular KCl (10–90 mM). Constrictor
responses in endothelium-intact arteries from AIR and DE-exposed rats were similar
(Figure 2A). Removal of the endothelium augmented KCl-mediated constriction in both
groups and responses were still not different between groups (Figure 2B and 2C).
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Figure 1: Percent vasoconstriction to increasing concentrations of ET-1 in the presence
(A) and absence (B) of a functional endothelium in coronary arteries from AIR and DEexposed animals. Endothelium-intact arteries displayed augmented vasoconstriction to
ET-1 following DE exposure (* different from AIR, p < 0.05). This difference in ET-1
reactivity was abolished with endothelium removal.
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Figure 2: Comparison of KCl-induced constriction in endothelium-intact and -disrupted
coronary arteries. There were no differences in vasoconstriction to increasing
concentrations of KCl in intact arteries (A). Removal of the endothelium also did not
affect KCl-induced constriction in arteries from either the AIR (B) or DE-exposed (C)
groups
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Coronary arteries from AIR and DE-exposed rats displayed myogenic tone that was not
different between groups (17 ± 4% and 20 ± 5%, respectively) that was abolished with
endothelium removal (Figure 2). In endothelium-intact arteries, low concentrations of
KCl (<30 mM) maximally dilated arteries from both groups and arterial diameter in Ca2+free PSS was not different between AIR and DE-exposed groups (192 ± 9 versus 188 ± 9
µm, respectively).
Enhanced ET-1 vasoconstriction is NOS-dependent. NOS inhibition with L-NNA
(100 µM) augmented constrictor sensitivity to ET-1 in the AIR group (Figure 3A)
compared with vehicle. In contrast, NOS inhibition diminished ET-1 constriction in the
DE-exposed group at low concentrations without affecting the maximum constriction
(Figure 3B). L-NNA treatment augmented the KCl response in both groups so that, as in
the untreated arteries, KCl-induced constriction was not different between groups in the
presence of the NOS inhibitor (Figure 4).
ETBR mediates augmented ET-1 constriction following DE. BQ-788 did not alter
ET-1-mediated vasoconstriction in the AIR group (Figure 5A). However, ETBR
antagonism with BQ-788 diminished ET-1-mediated vasoconstriction in coronary arteries
from the DE-exposed rats (Figure 5B), normalizing constrictor responses to those in the
AIR group. In the absence of a functional endothelium, BQ-788 slightly diminished ET1-mediated constriction in both groups (Figure 6). The majority of ET-1-mediated
vasoconstriction was prevented following ETAR blockade with BQ-123 in endotheliumintact coronary arteries from both groups. Arteries from DE-exposed animals still
displayed a small constrictor response to 10 nM ET-1 in the presence of ETAR blockade
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Figure 3: Constrictor response to ET-1 in the presence or absence of NOS inhibition. At
higher concentrations of ET-1, L-NNA (100 μM) augmented vasoconstriction compared
with vehicle (* p < 0.05) in the AIR group (A). NOS inhibition did not affect maximal
ET-1 constriction in the DE-exposed group (B) but blunted constriction at lower
concentrations of ET-1 (* different from vehicle, p < 0.05).
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Figure 4: Constrictor responses to KCl in the presence or absence of L-NNA (100 μM).
NOS inhibition augmented KCl-induced constriction similarly in the AIR (A) and DEexposed (B) groups (* different from vehicle, p < 0.05).
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Figure 5: Constrictor response to ET-1 following ETBR antagonism in endothelium-intact
coronary arteries. BQ-788 (10 μM) did not affect ET-1 constriction in arteries from the
AIR group (A). Vasoconstriction was significantly diminished in arteries from DEexposed animals (B) following BQ-788 treatment (* different from vehicle, p < 0.05).
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Figure 6: Constrictor response to ET-1 following ETBR antagonism in endotheliumdisrupted coronary arteries. Compared with vehicle, BQ-788 (10 μM) diminished ET-1
constriction in arteries from AIR (A) and DE-exposed (B) animals (* p < 0.05).
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(Figure 7) that was abolished with endothelial disruption (supplemental figure S1).
Constriction to the thromboxane A2 mimetic U46619 (0.1 nM–1 mM) was not different
between groups (supplemental figure S2, p=0.87).
ET-1 and its receptors not altered by DE. Changes in AIR and DE coronary artery
expression of ETAR (1.01 ± 0.07 versus 1.08 ± 0.09, p=0.77) and ETBR (1.08 ± 0.20
versus 0.97 ± 0.20, p=0.68) were evaluated using quantitative real-time PCR and no
differences in transcript levels between groups were found (supplemental figure S3).
Circulating ET-1 was also not different between groups (Figure 8A).
Plasma NOx elevated following exposure. Following a 5-h exposure to DE (Figure
8B), plasma levels of NOx (9.5 ± 0.5 µM) were elevated almost two-fold compared with
NOx levels in animals exposed to air (4.0 ± 0.5µM, p < 0.05).
Inflammatory cytokine levels. Plasma levels of MCP-1, IL-4, IL-2, IL-6, IFN-γ
and GRO-KC were not different between AIR and DE rats while G-CSF, MIP-1α, IL-1β
and TNF-α were below detection limits (supplemental table S1, n = 4-5 per group).
Discussion
The major finding in this study is that inhaled DE caused a dramatic increase in
constrictor responses to ET-1 in endothelium-intact coronary arteries. The enhanced
response was only seen in arteries when the endothelium was intact, NOS was not
inhibited and ETBR were not blocked. Furthermore, DE exposure did not affect
constrictor responses to KCl-induced depolarization or to the thromboxane A2 mimetic,
U46619. Therefore it appears that DE inhalation suppresses the generation of an
endothelial vasodilator that opposes ET-1 constriction. Because inhibiting NOS and
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Figure 7: Constrictor response to ET-1 following ETAR antagonism in endothelium-intact
coronary arteries. BQ-123 abolished ET-1 constrictor response in arteries from the AIR
animals. Vasoconstrictor response to ET-1 was inhibited in the arteries from the DEexposed animals except at the highest concentration tested (10 nM). * different from
AIR, p < 0.05.
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Figure 8: Plasma ET-1 peptide (A) and NOx (B) levels. Plasma ET-1 was not different
between groups following a single 5-h DE exposure. However, the NOx concentration in
plasma from DE-exposed animals was almost double that of plasma from the AIR rats (*
p < 0.05). n=4-5 per group.
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removing the endothelium similarly augmented ET-1-mediated constriction in arteries
from AIR animals but did not affect ET-1-mediated constriction in arteries from DEexposed animals, it appears that the lost vasodilator opposing ET-1 constriction is
endothelial NO. Although NOS inhibition did not augment responses to ET-1 in arteries
from DE-exposed animals, it did have the unexpected affect of diminishing ET-1mediated constriction at low concentrations, implying ET-1 causes a NOS-dependent
constriction (Figure 3B). Thus, acute DE exposure appears to augment ET-1 constriction
by reducing bioavailable NO and also by generating an endothelial-derived NOSdependent constrictor.
On the other hand, NOS inhibition might have reduced ET-1-dependent
constriction in the DE arteries by enhancing the production of a cyclooxygenase (COX)
derived vasodilator such as PGI2. NO has been shown to inhibit PGI2 production by
decreasing Ca2+ entry (43). Therefore increased NO production following DE exposure
may have inhibited PGI2 to cause the elevated ET-1 constriction in the untreated arteries.
Inhibition of endothelial NOS (eNOS) would restore PGI2 synthesis leading to the
observed diminished constriction in the presence of the NOS inhibitor. However, if NOinduced COX inhibition was the cause of the augmented constriction, then inhibiting
NOS should also have reduced constriction to KCl. This was not observed. In fact, NOS
inhibition increased KCl-induced constriction. Furthermore, blocking ETBR or removing
the endothelium also should not have diminished the constriction unless these were a
source of the constrictor. Therefore the loss of a COX-derived vasodilator following DE
exposure does not appear likely but can only be truly defined by further investigation into
this pathway.
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An alternative possibility is that eNOS is actually the direct cause of the
augmented constriction. NOS-derived vasoconstrictors can be generated when the
enzyme is uncoupled. Usually, the heme-containing homodimer eNOS generates NO (1;
12; 34). However, components of DE can generate reactive oxygen species (ROS) (4; 14)
that react with NO to form peroxynitrite and diminish NO bioavailability. ROS, including
peroxynitrite, oxidize the requisite NOS co-factor BH4, leading to NOS uncoupling (12).
The superoxide generated by uncoupled NOS can further augment tone both by
exacerbating NOS uncoupling and directly mediating vasoconstriction (41; 49).
Therefore, DE-generated ROS could lead to NOS uncoupling, depleting bioavailable NO
and generating a NOS-dependent constriction.
Unlike ET-1-stimulated NOS activation, basal NO production does not appear to
be different between groups. This is concluded from the observation that constrictor
responses to KCl were the same in endothelium-intact coronary arteries from AIR and
DE-exposed animals, and NOS inhibition similarly augmented KCl constriction in both
groups (Figure 2A). The enhanced KCl-induced constriction following NOS inhibition
indicates basal NO diminishes vascular tone. However, ET-1-stimulated NOS activation
appears to be disrupted in the coronary arteries from the DE-exposed rats. That is, ET-1
activates ETBR on both the vascular endothelial and smooth muscle cells (22) to elicit
smooth muscle-dependent constriction and endothelium-dependent dilation (18; 22). The
final level of tone is the sum of these two responses. With KCl-induced depolarization
and thromboxane receptor activation, the response is primarily mediated by activation of
smooth muscle pathways that are modulated by basal rather than stimulated endothelial
dilators. Thus, the selective augmentation of ET-1 constriction that is prevented by
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removing the endothelium, blocking ETBR, or inhibiting NOS suggests that DE affects
ET-1-stimulated endothelial NOS but not basal activity of the enzyme.
Vascular smooth muscle cells express both ETAR and ETBR which have been
shown to form functional dimers modulating intracellular signaling. ET-1 stimulation of a
homodimer of either receptor elicits a transient elevation of intracellular Ca2+ while
activation of a heterodimer causes a sustained intracellular Ca2+ elevation (11). Therefore
increased heterodimer expression would lead to increased vasoconstriction. However,
selective inhibition of either ETAR or ETBR alone does not affect heterodimerization and
does not diminish the ability of heterodimer pairs to mobilize Ca2+ (11; 13). Therefore in
the presence of heterodimerization, both receptors must be blocked to prevent ET-1induced constriction. Because either ETAR or ETBR blockade alone diminished
constriction in both AIR and DE endothelium-denuded arteries, this suggests the smooth
muscle effect is not through a heterodimer effect. Furthermore, the effect of ETBR
blockade was much greater in the endothelium-intact DE arteries further supporting an
endothelial ETBR mediated dysfunction.
A lack of effect of DE on basal NOS activity is also suggested by the observation
that there is an increase rather than a decrease in circulating NOx. Although the origin of
the plasma NOx was not determined, the elevated plasma NOx is likely due to the high
level of NO in DE (30). It is intriguing to speculate that this elevated exogenous NO
might be the factor that uncouples endogenous NOS to contribute to the impaired NO
generation. Previous studies have suggested that exposure to high levels of NO can
indeed nitrosylate eNOS (32), but future studies with DE and NO will be needed to
directly address this possibility.
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The role of ETBR in the activation of the NOS pathway was evaluated using the
selective receptor antagonist BQ-788. In endothelial disrupted arteries, BQ-788 had a
modest effect in diminishing the ET-1 constriction in both groups (Figure 6), indicating a
small contribution of smooth muscle ETBR to the ET-1 response. BQ-788 did not affect
ET-1-mediated constriction in endothelium-intact coronary arteries from the AIR group
(Figure 5A), suggesting the combined blockade of endothelial ETBR-mediated dilation
and smooth muscle ETBR-mediated constriction may cancel each other out, leading to no
observed effect in endothelium-intact arteries. Supporting this possibility is the
observation that ET-1-mediated constriction in endothelium-intact arteries from the AIR
group is abolished in the presence of the ETAR antagonist BQ-123 (Figure 7), such that
opposing actions of activated endothelial and smooth muscle ETBR would be seen as no
ET-1 constrictor response. In contrast, ETBR blockade diminished vasoconstriction
(Figure 5B) and a modest ETBR-dependent constriction remained following ETAR
antagonism (Figure 7) in endothelium-intact arteries from DE-exposed animals.
Therefore DE exposure appears to impair ETBR-mediated dilator function so that only a
constrictor effect remains. Furthermore, at low ET-1 concentrations, BQ-788 and L-NNA
both diminished constriction in endothelium-intact arteries, suggesting endothelial ETBR
stimulate NOS to produce vasoconstrictors in the DE arteries. In endothelial disrupted
arteries, very high concentrations of ET-1 were required to activate smooth muscle ETBR
and mediate constriction directly. Therefore, the overall effect of BQ-788 in
endothelium-intact arteries from DE-exposed animals is to normalize constriction to that
of the AIR arteries.

73

The observed alteration in coronary artery vascular function does not appear to be
mediated by an inflammatory response to DE. Plasma levels of cytokines shown to be
activated in acute inflammation were not different between groups following exposure.
This is in agreement with previous observations that exposure to similar levels of whole
DE alter vasoconstriction of mesenteric veins in the absence of inflammation (25).
Additionally, Exposure to DE bubbled PSS enhanced ET-1 mediated constriction in
coronary arteries (6) and mesenteric veins (25) similarly to the effects of whole body
exposure. These observations support a direct effect of component(s) of DE to alter
vascular function.
Perspectives and Significance
Enhanced vasoconstriction following DE exposure has been previously reported
in other animal models and in human studies. In ApoE knockout mice, DE inhalation
enhanced coronary artery constriction to ET-1 and depressed T-waves, indicating
myocardial ischemia (6). Similarly, DE exposure during stress testing in patients with
prior myocardial ischemia elicited dramatic changes in ST-segment voltage compared
with controls (31). Other systemic targets of DE include the mesenteric circulation where
enhanced constriction was normalized with NOS inhibition, suggesting NOS is
uncoupled in this bed as well (25). In human volunteers exposed to inhaled DE, brachial
artery diameter decreased and plasma ET-1 increased (35). Thus, DE effects on the
endothelium may augment coronary constriction to the endogenous vasoconstrictor ET-1
to decrease blood flow to the heart, contributing to cardiac events seen epidemiologically.
These negative effects of DE can be persistent and long-standing (45), possibly
contributing to the biphasic cardiovascular effects of elevated pollution levels.
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Figure S1: Constrictor response to ET-1 following ETAR antagonism in endotheliumdisrupted coronary arteries. BQ-123 abolished ET-1 constrictor response in arteries from
the DE animals. Vasoconstrictor response to ET-1 was inhibited in the arteries from the
AIR-exposed animals except at the higher concentrations. * different from AIR, p < 0.05.
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Figure S2: Constriction to the receptor mediated agonist U46619 in endothelium intact
arteries. Vasoconstrictor response to the thromboxane mimetic agonist was not different
between groups.
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from coronary arteries were not different between AIR and DE groups.
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G-CSF
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1837
1179
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IFN-γ
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TNF-α
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4775 ± 3092
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OOR< = Out of Range, Below
Expressed as pg/ml of plasma ± S.E.M
n = 4-5 per group

Table S1: Plasma cytokine levels from AIR and DE rats.
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CHAPTER 4
Specific Aim 2: Determine how DE-induced reactive oxygen species production affects
coronary artery contractility.
Hypothesis: DE-induced ROS production uncouples NOS to diminish NO-dependent
vasodilatation in coronary arteries.
Rationale: We have demonstrated that DE inhalation-augmented ET constrictor
sensitivity is endothelium dependent and NOS mediated. DE constituents are able to
induce ROS generation. This increased oxidative stress could deplete bioavailable BH4, a
necessary cofactor of NOS activity, to uncouple NOS resulting in further generation of
superoxide in place of NO. Augmented NOS mediated oxidative stress could therefore
contribute to the scavenging of NO to form peroxnitrite, a reducing agent of BH4. The
oxidation of BH4 could uncouple NOS to enhance the response to vasoconstrictors such
as ET-1. To address the role of DE-induced NOS dysfunction, we investigated coronary
artery vascular function using the endothelium-dependent vasodilator, ACh. Agonist
stimulation of NOS activity is usually accompanied by generation of other endothelial
dependent vasodilators. Therefore DE exposure may also affect COX and EDHF
vasodilator pathways, contributing further to the observed endothelial dysfunction and
DE effects on these pathways were also evaluated. We hypothesize that DE-induced ROS
uncouples NOS to diminish NO-dependent vasodilatation in coronary arteries.
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Abstract
Background and objective: Increased air pollutants correlate with increased incidence of
cardiovascular disease potentially due to vascular dysfunction. We have reported that
acute diesel engine exhaust (DE) exposure enhances vasoconstriction and diminishes
acetylcholine (ACh)-induced dilation in coronary arteries in a nitric oxide synthase
(NOS)-dependent manner. We hypothesize that acute DE inhalation leads to endothelial
dysfunction by uncoupling NOS.
Methods: Rats inhaled fresh DE (300 μg PM/m3) or filtered air (AIR) for 5 hrs. After offgassing, intraseptal coronary arteries were isolated and dilation to ACh recorded using
videomicroscopy.
Results: Arteries from DE exposed animals dilated less to ACh than arteries from AIR
exposed animals. NOS inhibition did not affect ACh dilation in control arteries but
increased dilation in the DE group, suggesting NOS does not normally contribute to
ACh-induced dilation in coronary arteries but does contribute to endothelial dysfunction
following DE inhalation. COX inhibition did not affect ACh dilation in the DE group, but
combined inhibition of NOS and COX diminished dilation in both groups and eliminated
inter-group differences suggesting the two pathways interact. Superoxide scavenging
increased ACh dilation in DE arteries eliminating differences between groups.
Tetrahydrobiopterin (BH4) supplementation with sepiapterin restored ACh-mediated
dilation in the DE group in a NOS dependent manner. Superoxide generation
(dihydoethidium staining) was greater in DE arteries and superoxide scavenging or NOS
inhibition reduced the DHE signal in DE but not AIR arteries.
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Conclusion: Acute DE exposure appears to uncouple NOS increasing ROS generation
and causing endothelial dysfunction, potentially due to depletion of BH4 limiting its
bioavailability.
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Introduction
Exposure to vehicular pollutants is associated with exacerbation of both
cardiovascular and respiratory diseases (13; 29; 30; 36; 39). Diesel engine exhaust (DE)
is an important contributor to urban air pollution (4; 17; 31). Although the exact
components of DE responsible for its effects have yet to be defined, both short term and
chronic DE exposure is associated with arrhythmias, adverse cardiac events (9; 28; 33)
and endothelial dysfunction that diminishes vasodilator response in systemic arteries
(12). Multiple pathways regulate endothelium dependent vasodilatation including the
release of nitric oxide (NO) and prostacyclin (PGI2) from the nitric oxide synthase (NOS)
and cyclooxygenase (COX) pathways, respectively. Additionally, activation of small
(SK) and intermediate (IK) Ca2+ dependent potassium channels can result in the
hyperpolarization and ultimately the relaxation of the vascular smooth muscle. However,
short-term inhalation of dilute DE has been shown to inhibit forearm vasodilation to both
acetylcholine (ACh) and the NO donor, or sodium nitroprusside, in healthy volunteers
(21; 37) suggesting that DE exposure may specifically affect signaling downstream of
NO.
Endothelial NOS (eNOS) is a homodimeric protein that generates NO from the
conversion of L-arginine to L-citrulline. NO inhibits platelet aggregation, leukocyte
adherence, and vascular smooth muscle proliferation to regulate vascular homeostasis (2;
16; 24).

Synthesized NO diffuses into adjacent vascular smooth muscle where it

activates soluble guanylate cyclase to reduce intracellular Ca2+ concentrations and
decrease vascular tone, leading to vasodilation. The eNOS cofactor 5,6,7,8tetrahydrobiopterin (BH4) is required for the production of NO, possibly by stabilizing
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the physical and/or electrochemical coupling of the NOS dimer, and is generated from
guanosine-5'-triphosphate through a de novo pathway or is recycled from the oxidized
form of BH4, 7,8-dihydrobiopterin (BH2) by dihydrofolate reductase (34).
DE exposure increases oxidative stress within the vasculature (20), which can
potentially increase the oxidation of BH4 to BH2, thereby limiting the bioavailability of
this essential cofactor. Depletion of BH4 or increases in BH2 electrochemically uncouple
eNOS, resulting in the generation of superoxide radical (O2-) rather than NO (8; 34). In a
cascade fashion, peroxynitrite (ONOO-) production from the reaction of O2- and NO not
only depletes bioavailable NO but can also oxidize BH4 to catalyze further eNOS
uncoupling. We have previously reported that vasoconstriction is augmented in systemic
arteries from DE exposed rodents and that the augmented constriction is endothelium
dependent and can be reversed with NOS inhibition (5; 6; 15). The aim of this study was
to evaluate agonist-mediated vasodilation in coronary arteries from healthy rats exposed
to DE. We hypothesized that DE-induced reactive oxygen species (ROS) uncouple NOS
to diminish NO-dependent vasodilatation in coronary arteries.
Methods
Animals: All animal protocols were reviewed and approved by the Institutional
Animal Care and Use Committee of the Lovelace Respiratory Research Institute (LRRI)
and the University of New Mexico and conform to National Institutes of Health (NIH)
guidelines for animal use to ensure animals were treated humanely and with regard for
the alleviation of suffering. Male Sprague-Dawley rats (250–300 g, Charles River
Laboratories) were housed in quarantine for 14 days following receipt, then acclimated to
exposure chambers for 7-14 days. Within the Hazelton 2000 chambers, rats were housed
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in standard shoebox cages and maintained on a 12:12 h light:dark cycle with food and
water available ad libitum prior to exposures. Food was withdrawn during DE exposure.
DE exposure: Rats were exposed to 300 g particulate matter (PM)/m3 DE in a
sealed chamber for 5 h representing the daily PM exposure limit set by the US
Environmental Protection Agency. Although daily exposure in the majority of the US
population is far lower in terms of PM, occupations requiring the use of diesel engines
have exposure conditions similar to this study (32). The DE system has been previously
characterized and produces levels of CO and NOx at approximately 3 ppm and 4 ppm,
respectively (19). Control (AIR) rats were housed identically but exposed to filtered air.
DE was generated from a single-cylinder, 5500-watt, Yanmar diesel generator using
nationally certified diesel fuel at the LRRI facility. Electrical current was drained from
the engine to provide a constant 90% load during operation to assure consistent
emissions. The particle concentration was monitored by sampling on 47-mm Pallflex
(Pall-Gelman) filters. Filters were collected two times a day (every 3 hours) for each DE
exposure chamber and once per day from the control chamber. Pre-filter and post-filter
weights were measured with a microbalance and desired concentrations of the emissions
were attained by diluting the direct exhaust with filtered air. Exposure chamber
temperature and humidity were monitored throughout exposures and temperatures were
maintained at 20–25°C (19).
Isolated artery preparation: At the end of the 5-h exposure, chambers were offgassed for 30 minutes and the rats removed and euthanized with sodium pentobarbital
(200 mg/kg, i.p.). Hearts were immediately removed and intraseptal coronary arteries
(resting inner diameter, AIR: 176 ± 7, DE: 180 ± 7 µm) were isolated and placed in
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chilled physiological saline solution (PSS, in mmol/L, 129.8 NaCl, 5.4 KCl, 0.83 MgSO4,
19 NaHCO3, 1.8 CaCl2, and 5.5 glucose) aerated with 21% O2, 6% CO2 and 73% N2.
Each artery was used for only one experimental protocol. Both ends of the arteries were
cannulated onto glass micropipettes in a tissue chamber (Living Systems, CH-1) and
secured with silk sutures within 30 minutes of isolation from the heart. Vessels were
stretched to approximate in situ length and pressurized to 60 mmHg with PSS in the
lumen absent of flow and superfused at a rate of 5 mL/min with 37oC oxygenated PSS.
At the end of the experiment, Ca2+-free PSS (3.7 mmol/L EGTA) was superfused for 60
min to fully relax the vessel (Ca2+ free inner diameter, AIR: 219 ± 4, DE: 224 ± 4 µm).
Vasodilator studies: Vessel chambers were placed on the stage of an inverted
Nikon Eclipse TS 100 microscope fitted with a video camera connected to a data
acquisition computer. Inner diameter changes were recorded using edge detection
software (IonOptix) as described previously (10). Arteries were treated for at least 30
minutes with various drug treatments or vehicle (Veh) in the superfusate and in the lumen
prior to dilation with increasing concentrations of acetylcholine (ACh, 0.001–100
μmol/L) in U46619 preconstricted arteries (constricted to ~50% of fully relaxed
diameter). The contribution of key endothelial dilator pathways were determined using
nitric oxide synthase (NOS) inhibitor (N-nitro-L-arginine, L-NNA, 100 µmol/L),
cyclooxygenase inhibitor (aspirin, 10 µmol/L) and small (apamin, 100 nmol/L) and
intermediate (Tram-34, 1 µmol/L) Ca2+ activated K+ channels. The role of NOS
uncoupling and ROS mediated endothelial dysfunction following exposure was assessed
with BH4 donor (sepiapterin, 1 µmol/L) and the cell permeate superoxide dismutase
(PEG-SOD, 150 U/mL), respectively.

97
ROS Measurement: Oxidation of the cell permeable fluorescent probe,
dihydroethidium (DHE), by O2- generates ethidium+ which then intercalates into DNA of
cells (40; 41). Septum from both AIR and DE exposed animals were embedded in OCT
(TissueTek) without fixation and flash frozen with liquid nitrogen. Septal sections (10
µm) were allowed to dry on glass slides for 30 minutes at room temperatures proceeded
by treatment with PBS, LNNA (100 µmol/L) or the superoxide dismutase mimetic, tiron
(10 µmol/L) for 30 minutes at 37ºC followed by incubation with DHE (10 µmol/L) with
inhibitors for 45 minutes at 37ºC. Coverslips were mounted on each slide with
Vectashield. Images of coronary arteries were captured on a Nikon Optiphot fluorescence
microscope using a Chroma TRITC filter set (excitation: 510-560 nm; emission: 570-650
nm). Data are expressed as average intensity (integrated intensity per area of region of
interest) from one artery per rat for four rats in each group and were gathered using
Metamorph software (v7.0).
Statistical analysis and calculations: Dilator responses were analyzed using twoway repeated-measures ANOVA with Student-Newman-Keuls post hoc analysis (Sigma
Stat, v3.5) for differences between groups, concentrations, and interactions. Probability
levels less than 0.05 were considered significant. Data were tested for normality as part
of the two way ANOVA analysis. All dilation data are expressed as a percent reversal of
active tone (50% PE preconstricted) and is calculated as the percent change in inner
diameter as shown below.
Percent dilation:

Diameter ( ACh) - Diameter (50% Preconstricted)
* 100 [1]
Diameter (Ca 2 Free) - Diameter (50% Preconstricted)
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Results
DE inhibits ACh-mediated vasodilatation. First, we determined if diesel exposure

affected endothelium-dependent responses to ACh. Coronary arteries from DE exposed
rats (n=9) had diminished vasodilation to ACh compared to arteries from air-exposed rats
(n=5, p = 0.006, figure 1a). Maximal agonist induced dilation in AIR (94 ± 4% ) was
greater than DE arteries (44 ± 12%, p = 0.007). In Ca-free PSS, the inner diameter of
fully relaxed coronary arteries was not different between AIR and DE groups (200 ± 6
versus 210 ± 13 µm, respectively). These findings note a substantial reduction in dilatory
response after a single acute exposure to DE.
NOS, but not COX, inhibition restores dilation following DE. To elucidate which

endothelium dependent pathways were altered by DE exposure, we investigated the roles
of NOS, COX and SK and IK channels. NOS inhibition (n=6) augmented ACh-mediated
dilation in the DE group compared to vehicle treatment (p = 0.011, figure 1b), restoring
dilation to that in untreated AIR arteries (p = 0.945) suggesting a NOS-dependent
inhibition of dilation. Unexpectedly, L-NNA (100 µmol/L) did not alter dilation in the
AIR group compared to untreated controls (n=6, p = 0.456, figure 1c). In contrast, COX
inhibition with aspirin (10 µmol/L) modestly inhibited dilation in the AIR arteries (n=6, p
= 0.040, figure 2a) but did not affect ACh mediated responses in the DE group (n=9,
figure 2b).
The combined inhibition of NOS and COX blunted ACh-mediated dilation in
both DE and AIR group (n=10 and n=11, respectively, figure 3a) compared to vehicle
treatment within group. Blockade of SK and IK with Tram-34 (100 nmol/L) and apamin
(1 µmol/L), respectively, diminished ACh-mediated dilation significantly and similarly in
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Figure 1: ACh vasodilation was diminished following exposure to DE compared to AIR
control in vehicle treated coronary arteries (A). NOS inhibition with L-NNA (100
mol/L) restored the blunted ACh mediated dilation (B) without affecting dilation in the
AIR group (C). * different from AIR or Veh, p < 0.05.
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Figure 2: Pretreating coronary arteries with aspirin (10 mol/L) to inhibit COX
diminished ACh mediated dilation in the AIR group (A) but had no effect in the DE
exposed group (B) compared to vehicle treatment. * different from Veh, p < 0.05
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Figure 3: Inhibition of both NOS (L-NNA, 100 mol/L) and COX (aspirin, 10 mol/L)
diminished dilation to ACh in both groups and eliminated between groups differences
(A). Although blockade of small and intermediate Ca2+ dependent K+ channels blunted
dilation in arteries from both groups, dilation was still less in the DE compared to the
AIR group (B). * different from AIR, p < 0.05.
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both groups (n=6 per group, figure 3b) compared to vehicle treatment but the residual
dilation was less in DE than AIR arteries. Finally, combined inhibition of NOS, COX, SK
and IK completely abolished dilation in both groups (data not shown). Although
inhalation of DE alters other endothelium-dependent dilator pathways, the impairment of
NOS function, primarily, results in diminished ACh-mediated dilation.
Diminished dilation following DE is restored with BH4. To determine if

supplementation with the cofactor BH4 could rescue NOS function, arteries were treated
with sepiapterin (1 µmol/L) which increases BH4 levels via the salvage pathway of BH4
biosynthesis. Sepiapterin treatment of isolated arteries augmented and restored AChmediated dilation in DE arteries (n=5, figure 4a) while blunting dilation in the AIR group
(n=8, Figure 4b). The effects of sepiapterin on dilation were blocked by concurrent NOS
inhibition (n=5 per group, figure 4b and 4d) such that there was no difference from
vehicle treatment within each group. Following exposure, BH4 levels appear to be
insufficient to maintain NOS function.
Superoxide scavenging prevents effects of DE exposure. DE exposure can

increase oxidative stress that can reduce both NO and BH4 levels (14; 20). Coronary
artery superoxide levels were evaluated with the cell permeable fluorescent probe DHE.
Septal coronary arteries from rats exposed to DE induced greater DHE fluorescence than
arteries from air exposed rats. Scavenging O2- with tiron or inhibition of NOS had no
effect on DHE fluorescence in AIR, but diminished and normalized fluorescence in DE
compared to AIR (n=4 per group, Figure 5) indicating increased O2- generation following
DE exposure that is NOS dependent.
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Figure 4: Dilation to ACh was augmented in arteries from the DE group following BH4
supplementation (sepiapterin, 1 mol/L) compared to Veh treatment (A). In the presence
of NOS inhibition (L-NNA, 100 mol/L), the effect of sepiapterin was blocked (B).
Dilator response to ACh was blunted in arteries from the AIR group following BH4
supplementation (sepiapterin, 1 mol/L) compared to Veh treatment (C). In the presence
of NOS inhibition (L-NNA, 100 mol/L), the effect of sepiapterin was blocked (D). *
different from Veh, p < 0.05.
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Figure 5: DHE fluorescence was greater in PBS treated (Veh) coronary arteries from DE
exposed compared to AIR rats. Either tiron (10 mol/L) or L-NNA (100 mol/L)
treatment ex vivo prevented the DE induced increase in fluorescence without effect in
AIR arteries. * different from AIR Veh, p < 0.05. # different from DE Veh, p < 0.05. n =
4 per group.
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We scavenged ROS with superoxide dismutase (SOD) to determine if oxidative
stress mediates the vascular changes of DE exposure. Treatment of AIR arteries with
PEG-SOD (150 U/ml) had no effect on ACh-mediated vasodilation compared to vehicle
treatment. Similar to NOS inhibition or BH4 supplementation, superoxide scavenging
with PEG-SOD restored dilation in the DE group so that dilation was not different from
arteries in the AIR vehicle treatment group (n=4 per group, Figure 6). Exposure to DE
appears to augment superoxide generation that inhibits agonist induced dilation.
Discussion

In the present study, acute exposure to DE impaired ACh-mediated dilation in
coronary arteries from healthy rats, an effect that was reversed by NOS inhibition.
Supplementation with the BH4 precursor sepiapterin or scavenging ROS in vitro also
completely restored ACh mediated dilation after DE exposure. Although COX inhibition
did not alter dilation in either group, combined blockade of NOS and COX significantly
blunted dilation in arteries from both AIR and DE exposed animals. Additional inhibition
of SK and IK channels completely abolished dilation, with no difference between DE and
filtered air groups. Combined, these observations suggest that DE exposure diminishes
ACh-mediated dilation by selectively disrupting NOS-mediated responses.
The most likely mechanism for loss of ACh-induced dilation in the DE arteries is
oxidative stress-induced uncoupling of NOS. As sepiapterin supplementation antagonized
the effects of DE, the current results suggest NOS may be uncoupled due to a loss of
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Figure 6: Scavenging of superoxide with PEG-SOD (150 U/mL) restored the dilator
response to ACh in the DE group but did not affect responses in the AIR group.
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BH4. Uncoupled NOS generate O2- rather than NO, which can further scavenge BH4 (14;
23; 26). BH4 is necessary for physical and electrochemical coupling of NOS, and the
depletion of this cofactor in an oxidative environment further exacerbates NOS and
endothelial dysfunction. In the present study, supplementation with sepiapterin, a
precursor to BH4, fully restored ACh-mediated dilation in coronary arteries from the DE
exposed group suggesting loss of this co-factor led to the impaired dilation.
Inhibition of NOS in DE-exposed rats prevented the effects of sepiapterin,
suggesting the effect of BH4 was to recouple NOS. In contrast, BH4 supplementation in
coronary arteries from air exposed animals had the opposite effect, diminishing
endothelium-mediated dilation. These effects also appear to be NOS dependent as
treatment with L-NNA prevented sepiapterin blunting of dilation in the AIR arteries.
Sepiapterin increases levels of BH2, the oxidized form of BH4, which is converted to BH4
by dihydrofolate reductase through the salvage pathway (35). If the salvage pathway is
saturated by excess BH2 levels, sepiapterin release of BH2 can inhibit NOS function by
competing with BH4 for NOS binding to mimic BH4 depletion and increase ROS
production by uncoupling NOS (8; 34). In this manner, sepiapterin may generate an
oxidative environment in the AIR arteries that is partially NOS driven, similar to the
effects of DE exposure. Inhibition of NOS in arteries from air exposed animals treated
with sepiapterin blunts ROS generation and restores endothelial function.
Basal levels of superoxide detected by DHE staining in coronary arteries were
elevated following DE exposure compared to the AIR group. This increase in superoxide
generation was further demonstrated by increased sensitivity to tiron and was blocked
with NOS inhibition supporting NOS mediated dysfunction resulting in generation of
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ROS. It was recently described that the specificity of DHE fluorescence may not
represent the intracellular levels of superoxide accurately using fluorescent microscopy
(42). Nonetheless, the current study attempted to address the flaws of this methodology
by comparing the tiron, a SOD mimetic, sensitive component rather than the raw values.
Further supporting that DE effects were mediated by elevated levels of ROS, scavenging
ROS with PEG-SOD in coronary arteries from DE exposed animals restored agonist
mediated dilation but did not alter dilation in the AIR group. SOD catalyses the
conversion of O2- to hydrogen peroxide, which is further broken down to H2O and O2 by
catalase. The restoration of ACh-induced dilation with PEG-SOD may be partially
mediated by increased H2O2 which has been shown to be a vasodilator (22). However,
taken with the observations that NOS inhibition and BH4 supplementation also restore
endothelial function, the present data are more consistent with the conclusion that
following DE inhalation, uncoupled NOS generates O2-. The increase in O2- depletes
bioavailability of both NO and BH4 to potentiate further uncoupling of NOS. In contrast
to our findings, Courtois and colleagues found impaired NO-dependent relaxation
following intratracheal PM instillation that was secondary to inflammation altered
smooth muscle sensitivity to NO and ROS independent (7). As previously reported, acute
inhalation of DE at moderate levels (i.e., 300 µg/m3) does not induce measureable
changes in pulmonary inflammatory markers nor does it alter vascular smooth muscle
sensitivity to basal NO (6). A major difference between our study design and that of
Courtois as well as Nurkiewicz et al 2006 is that we investigated effects immediately
following exposures rather than 6-72 hours later. Thus, inflammatory contributions to the
systemic vasculature are minimal in our model as evidenced by lack of cytokine
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induction, while at later timepoints evidence of rolling and adhering leukocytes and
dexamethasone-sensitive vascular impairments can be seen. The differences in exposure
method, instillation of urban PM versus inhalation of dilute whole DE, and of vascular
bed of interest, pulmonary versus systemic, between Courtois and the present study may
lead to the different mechanisms of NO impairment observed in these two studies. In fact,
these differences provide insight into the multiple mechanisms leading to endothelial
dysfunction following inhaled versus instilled exposure to air pollution.
Interactions between the NOS and COX pathways have been demonstrated
previously in both cultured cells and isolated arteries (3) and are apparent in the current
study. In AIR arteries, COX inhibitors only modestly diminished ACh-mediated dilation
while NOS inhibition had no effect; however, the combined inhibition greatly blunted
agonist induced dilation. These results suggest the two pathways exhibit functional
redundancy, such that pharmacological blockade of one pathway can be offset by
activation through the alternate pathway. Thus, inhibition of both NOS and COX blunts
dilation more than the sum of inhibiting either pathway alone. The synergistic effect of
combined inhibition of NOS and COX was seen in both AIR and DE arteries suggesting
the NOS/COX interaction is not lost after DE exposure and plays an essential role in the
coronary artery.
Blockade of the SK and IK channels inhibited dilation in both groups but dilation
was still blunted in the DE compared to AIR arteries in the presence of the inhibitors.
Therefore, activation of SK and IK channels contribute to ACh-induced dilation but do
not appear to be altered by DE exposure. Interpretation of these results is complicated
because these potassium channels regulate endothelial Ca2+ entry, which affects both
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NOS and COX activity. Inhibition of these channels induces membrane depolarization
that reduces the electrochemical driving force for Ca2+ entry upon agonist stimulation,
(11) potentially reducing both NOS and COX activation. In sum, the data show that AChinduced dilation in coronary arteries is mediated by NOS, COX, SK, and IK, as combined
inhibition of these pathways was necessary to completely abolish dilator responses.
Both human and animal studies suggest the NOS pathway is impaired by DE
exposure but mechanistic details have not been fully elucidated. Recently, Nurkiewicz
and colleagues (25) found that NO availability is reduced in vessels isolated from rats
exposed acutely to ultrafine particulate matter. However, it was not clear whether NOS
was uncoupled or whether generated NO was scavenged; both mechanisms appear likely.
Previously, we demonstrated that inhaled DE enhances ET-1 vasoconstriction in rat
coronary arteries by stimulating uncoupled NOS-dependent constriction via endothelial
endothelin B receptor (6). Langrish and colleagues demonstrated similar findings in
healthy human volunteers exposed to DE, where circulating ET-1 was not different but
ET-1 constrictor sensitivity was enhanced, apparently via endothelin B receptor pathways
(18). In the present study, DE exposure also diminishes ACh-mediated dilation, which
was restored by NOS inhibition or BH4 supplementation, further supporting the
conclusion that DE exposure uncouples eNOS. ROS scavenging also reversed the effects
of DE inhalation supporting a role for increased oxidative stress which can decrease NOS
mediated dilation through multiple pathways. Elevated ROS levels presumably oxidize
BH4 thereby decreasing availability of this necessary cofactor for NO generation
resulting in NOS uncoupling. BH4 supplementation provides enough excess cofactor that
NOS stays in a coupled state preventing the effects of DE inhalation. Furthermore, NO
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can be scavenged by ROS to form peroxynitrite, which not only depletes NO
bioavailablity but can nitrosylate proteins to alter function (1). Further studies are needed
to determine if the initial source of ROS is DE or uncoupled NOS. It may be that DE
provides the initial oxidative burst that leads to the uncoupling of NOS resulting in a feed
forward cycle leading to endothelial dysfunction.

Alternatively, DE may provide a

substrate for NOS uncoupling that is not related to ROS.
It is clear that pharmacologically-induced vasodilatation is blunted in healthy
volunteers (21; 37) and in animal models (6; 15) following acute inhalation of DE. It is
unclear if the alterations in vascular function in the current study persist at later time
points, which future studies will address. We speculate similar changes will be present
but waning over the following 24-72 hours as the vascular alterations in humans, which
have rapid onset (21) and parallel our observations in the coronary arteries, persist at least
24 hours after cessation of exposure (37). Potentially, activation of uncoupled NOS
following DE inhalation may result in prolonged endothelial dysfunction that is only
slowly reversed after exposure. Likely vascular endothelium must recover by the de novo
production of NOS protein along with cofactors such as BH4 which, depending on the
potency of exposure, abundance of precursors and nutrients, and genetic factors, could
take several days to recuperate. Furthermore, DE inhalation can increase circulating
levels of the endogenous vasoconstrictor, ET-1, in both animal (38) and human studies
(27) and enhance vascular responsiveness to ET-1 (6). Such changes would be expected
to further diminish dilation and enhance constriction in coronary vessels, thereby
increasing risk and/or severity of coronary occlusive sequelae. Thus, susceptible
individuals with underlying cardiovascular conditions may have augmented coronary
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vasoconstriction following DE exposure, contributing to the increased cardiovascular
events seen epidemiologically following elevated pollution levels.
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CHAPTER 5. DISCUSSION
Numerous epidemiological studies have demonstrated that deteriorating air
quality levels are associated with increased incidence of cardiovascular morbidity and
mortality. Exposure to air pollution elevates the risk of arrhythmias and myocardial
infarctions (70; 71). A major contributor to air pollution is DE from the use of on- and
off-road diesel engines worldwide (91). Short term inhalation of dilute DE has been
shown to exacerbate myocardial ischemia (56) and impair brachial artery vasodilator
function in humans (57), possibly contributing to the increase in hospital admissions for
cardiovascular events following exposure to traffic related air pollution (78). However,
the mechanism by which DE elicits cardiovascular alterations is poorly understood and
the elucidation of the cellular signaling that potentially leads to decreased oxygen
delivery to the heart has been the focus of this dissertation.
Only a handful of studies are available to date examining the in vivo human
vascular changes following DE exposure. Furthermore, the technical difficulty of
studying human coronary arteries in vivo limits investigation of this vascular bed.
However, the brachial artery has been established as a noninvasive surrogate for the study
of the coronary artery function because of the similarities in endothelium-mediated
vasomotor function between these two artery beds (6; 83). Peretz et al, recently
demonstrated that acute inhalation of 200 µg PM/m3 DE in healthy volunteers decreased
resting diameter of the brachial artery compared to arteries in controls breathing filtered
air inhalation (69). In similar studies, agonist-induced brachial artery dilation of healthy
volunteers was blunted by a brief exposure to 300 µg PM/m3 DE compared to control,
and the impoariment persisted for up to 24 hours post exposure. In contrast, endothelium
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independent dilation was not altered between groups (57; 90). Furthermore, DE exposure
elicited brachial artery vasoconstriction to infused ET-1 that was absent in the control
group (51). These studies suggest endothelial function is impaired following acute
inhalation of DE.
Various animal studies with DE have observed effects that reflect the vascular
changes observed in human studies. ACh mediated relaxation was attenuated in rat aortic
rings bathed in diesel exhaust particles (DEP) suspended solution (55). Likewise, Ikeda
and colleagues found that DEP exposed rat aortic rings demonstrated diminished
endothelium-dependent relaxation to ACh (43). ET-1 mediated vasoconstriction was
augmented in mesenteric veins from mice exposed to DE (350 µg PM/m3) by inhalation
compared to veins from filtered air-exposed animals (48). Correlating with both human
and animal studies, we observed acute inhalation of 300 µg PM/m3 DE augmented ET-1mediated constriction and blunted ACh-mediated dilation of intraseptal coronary arteries
from healthy rats compared to responses in arteries from filtered air-exposed rats.
Enhanced ET-1-mediated vasoconstriction after inhalation of DE was only
observed in endothelium-intact coronary arteries. Furthermore, exposure did not alter
endothelium-independent constrictor responses to KCl-induced depolarization or to the
thromboxane A2 mimetic agonist, U46619. Thus, DE inhalation appears to suppress the
generation of an endothelium derived vasodilator that opposes ET-1 constriction, rather
than alter vasoconstrictor signaling in the vascular smooth muscle cell. NO is an
important

endothelium-derived

regulator

of

coronary

artery

vascular

tone.

Pharmacological inhibition of NOS to reduce NO synthesis decreases coronary basal
diameter and flow in addition to diminishing agonist-induced dilation (11; 61). Likewise,
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DEP exposure has been demonstrated to directly reduce NO generation (55; 62) to
enhance vascular tone (49). Thus, impairment of the coronary artery NO pathway was a
likely target of DE exposure.
Consistent with endothelium disruption, NOS inhibition augmented coronary
artery ET-1-mediated constriction only in the AIR group to normalize constrictor
responses between groups. Therefore, there was a loss of endothelial NO to oppose ET-1
constriction following DE inhalation. Unexpectedly, NOS inhibition diminished
vasoconstriction at low ET-1 concentration without altering maximal constriction which
suggested ET-1 elicited the generation of a NOS dependent vasoconstrictor following DE
exposure. Endothelial disruption similarly diminished ET-1 mediated vasoconstriction
without altering maximal response in DE arteries. Therefore, acute DE exposure
augments ET-1 constriction by generating an endothelial-derived NOS-dependent
constrictor in addition to reducing bioavailable NO.
Contrary to the vascular reactivity data suggesting diminished bioavailable NO,
we measured a 2-fold increase in plasma NOX levels, which has been used as an index of
vascular NO levels. Although the origin of the plasma NOx was not determined in the
present studies, the high level of NO in DE could contribute to the observed elevation in
plasma NOx (54). Supporting this conclusion, rats exposed to pure NO by inhalation at a
comparable concentration found in whole DE had similarly increased plasma NOX levels
and enhanced vasoconstrictor sensitivity to ET-1 (47). Indeed, previous studies have
suggested that exposure to high levels of exogenous NO can uncouple endogenous NOS
(59), impairing NO generation. Although data is sparse linking ambient levels of NO to
related mortalities, Filleul and colleagues found increased risk for non-accidental death
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with elevated ambient NOX levels (28). Future studies will address the possibility of
excess NO in the whole DE as a contributing factor to the impairment of NO generation.
While systemic levels of NOX were elevated with acute DE inhalation, basal NO
production did not appear to be different in intraseptal coronary arteries. Constrictor
responses to the depolarizing agent, KCl, were not different in endothelium-intact
coronary arteries from AIR and DE-exposed animals. This is in contrast to a predicted
greater response in DE arteries if there was a generalized loss of basal NO production. In
addition, NOS inhibition augmented basal and KCl induced tone equally in both groups
further supporting the contention that basal NO levels are not different between groups.
In the KCl studies, low concentrations of KCl completely reversed basal tone (~20%) and
maximally dilated arteries in both groups, presumably through the activation of inward
rectifying potassium channels (Kir) and Na+/K+ ATPase on the vascular smooth muscle
(34). KCl induced constriction was also not different between groups after endothelial
disruption supporting the observation that DE exposure specifically impairs agonistinduced endothelium-dependent dilation.
It appears that ET-1-mediated NOS activation was disrupted in the coronary
arteries from the DE-exposed rats. Although ET-1 can bind to multiple receptors on the
vasculature to elicit differential effects, ET-1 mediated constriction is primarily through
the stimulation of ETAR in the coronary vasculature (35). However, activation of vascular
smooth muscle ETBR also elicits contraction of the muscle, while endothelial ETBR
stimulate release of endothelium dependent dilators, including NO (38; 42). Altghough it
is not clear if intraseptal coronary arteries express both receptors in the medial, muscle
layer, the final level of tone after ET-1 stimulation should be the sum of these responses.
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We used the selective receptor antagonist BQ-788 to assess the role of ETBR-mediated
activation of the NOS pathway. ET-1 constriction was diminished in both groups with
BQ-788 treatment in endothelial disrupted arteries indicating a minor contribution of
smooth muscle ETBR to the ET-1 constrictor response. ETBR antagonism in endotheliumintact arteries from DE-exposed animals diminished the ET-1 constriction, reducing the
response to that in untreated, intact AIR arteries. A modest BQ-788-sensitive constriction
persisted following ETAR antagonism suggesting DE exposure impairs ETBR-mediated
dilator function leaving only a constrictor effect. This constriction was nearly eliminated
with endothelial disruption in the presence of BQ-123 indicative that ETBR-mediated
constriction was endothelial in origin. Inhibition of ETBR and NOS similarly diminished
constriction in DE arteries at low ET-1 concentrations suggesting NOS dependent
vasoconstrictor production is stimulated by endothelial ETBR. Therefore, the overall
effect of ETBR antagonism in endothelium-intact arteries from DE-exposed animals was
to normalize constriction to that of the AIR arteries by apparent blockade of endothelial
activation of a NOS-mediated constriction.
Alterations in the ET-1 system in various disease states have previously been
shown to augment ET-1 constrictor sensitivity (25). In our studies, plasma ET-1 level
was not different between groups after a brief 5 hour exposure. This is in contrast to
previous reports of elevated plasma levels of ET-1 associated with air pollutant exposure.
This may be due to differences in the air pollutant sources (i.e., urban ambient particles)
affecting different molecular signaling pathways compared to DE. The discrepancy may
also result from the excessive exposure dose, approximately 10-fold greater than the
present study, used to elicit these observed changes (86; 94). Indeed, DE exposures
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comparable to the current studies in humans also found enhanced constrictor reactivity to
ET-1 infusion without differences in plasma ET-1 (51). However, Peretz observed
increased plasma ET-1 an hour after cessation of DE exposure in humans (69) suggesting
local elevations in ET-1 may require additional time to accumulate in the circulation, so
that any potential increase was missed by the current study. Another possibility is species
differences in responses and this may be more likely in the current study as preproET-1
transcript levels were not different between groups in a variety of tissues including
cardiac tissue.
Augmented ET-1 constriction could also be mediated by increased ET receptor
expression. In certain forms of hypertension, ETAR are unregulated and contribute to
enhanced ET-1 mediated vasoconstriction. Blockade of these receptors with BQ-123
completely abolished vasoconstrictor responses (4; 5). Generally, we did not find
alterations in ETAR or ETBR transcripts in various target tissues suggesting that acute DE
exposure likely does not alter receptor expression. This was supported by isolated artery
studies where endothelium disruption or NOS inhibition normalized and ETAR
antagonism eliminated, ET-1 constrictor responses. Because transcript levels do not
necessarily correlate with protein translation, additional studies to measure protein levels
will be needed to address this discrepancy and to confirm the mRNA findings.
DE potentially can alter formation of ET receptor dimers which can regulate Ca2+
mobilization. Formation of vascular smooth muscle ETAR and ETBR dimers has been
shown to differentially modulate intracellular Ca2+ signaling in the absence of receptor
expression changes. Stimulation of endothelin receptor homodimers elicits a transient
increase of intracellular Ca2+ while heterodimer activation causes a sustained elevation in
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intracellular Ca2+ (22). Increased heterodimer expression could therefore increase
vasoconstriction without changes in receptor expression. Heterodimer formation and
subsequent mobilization of Ca2+ is not affected by inhibition of either ETAR or ETBR
alone and blockade of both receptors is necessary to prevent ET-1 induced dilation (22;
33). Because ET-1 constriction was diminished in endothelium-disrupted arteries from
both groups with either ETAR or ETBR antagonism, our results imply smooth muscle ET
receptor heterodimerization does not mediate DE induced changes in vasoreactivity.
Further support of an endothelial ETBR mediated dysfunction was the observation that
the effect of ETBR blockade was greater in endothelium-intact DE arteries. Therefore, the
selective augmentation of ET-1 constriction that was prevented by endothelium
disruption, ETBR antagonism, or NOS inhibition suggests that DE affects ET-1stimulated endothelial NOS, but not basal, enzyme activity.
The production of NOS-derived vasoconstrictors generated from uncoupling of
the enzyme potentially contributed to augmented ET-1 constrictor response. Production
of NO requires the dimerization of eNOS monomers and binding of various cofactors,
including the redox sensitive BH4 (3; 29; 60). Endothelium dependent dilation was
improved with ROS scavenging (55) implying DE induced ROS generation inhibits NOS
function. DE has been shown to generate various ROS (8; 66) that can scavenge NO
forming peroxynitrite to diminish NO bioavailability (49). Peroxynitrite can uncouple
NOS by oxidizing BH4 to stimulate superoxide generation in place of NO (29). NOS
derived superoxide can further augment tone both by exacerbating NOS uncoupling and
directly mediating vasoconstriction (75; 98).
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Glutathione (GSH) is one of the many endogenous antioxidant systems found in
most cells that scavenge excess ROS. The tripeptide promotes proper enzymatic function
of NOS by scavenging ROS and ONOO- to prevent the oxidation of BH4. Oxidation of
GSH to GSSG can be reversed by GSSH reductase forming a regenerative redox cycle.
Glutamate-cysteine ligase (GCL) catalyzes the rate limiting step of GSH synthesis and
GCL polymorphisms are associated with lower plasma GSH and endothelial dysfunction
(63). Populations with this mutation have a greater risk for myocardial infarction and
potentially may be more susceptible to DE mediated effects (79). It is currently unknown
if DE affects GCL expression or activity but inhibition of this, or other antioxidant,
pathways would decrease the cellular capacity to modulate ROS levels and exacerbate the
effects of DE.
Basal levels of superoxide were higher in coronary arteries from DE exposed rats
compared to the AIR group supporting the hypothesis that ROS is a mediator of coronary
artery dysfunction following DE exposure. The specificity of DHE fluorescence for O2·was validated by the addition of tiron, a superoxide scavenger, which lowered the
fluorescent signal to the levels in AIR arteries. NOS inhibition similarly lowered the
DHE measured O2·- suggesting NOS dependent ROS generation was increased following
DE exposure. Collectively, the data indicate that DE exposure alters NOS coupling and
function with agonist stimulation and is not specific to ET. Therefore agonists that
activate the NOS pathway should show similar impairment in vascular function.
To address endothelium dysfunction following DE exposure more directly, we
assessed NOS function using the endothelium-dependent vasodilator ACh. AChmediated dilation was blunted in coronary arteries from DE exposed rats compared to
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AIR rats. This impaired dilator response was reversed with NOS inhibition, in support of
the generation and release of a NOS dependent constrictor following DE inhalation. NO
has been shown to be an important regulator of vascular tone in the coronary vasculature,
but NOS inhibition did not reduce ACh-induced dilation in the AIR group (11; 61). These
data suggest either NOS is not a major pathway for ACh-mediated dilation in these small
arteries or that compensatory dilator pathways were activated when NOS was blocked.
ACh mediates endothelium-dependent dilation by binding endothelial muscarinic
receptors to initiate a Ca2+ signaling cascade that not only stimulates NOS function, but
also activates other vasodilator pathways such as COX, SK and IK. Inhibition of COX
activity with aspirin did not affect ACh dilator response in the DE group, but modestly
diminished dilation in the AIR arteries compared to untreated AIR arteries. These data
suggest a loss of COX derived vasodilator(s) following DE exposure and imply 1) neither
NOS nor COX products mediate ACh dilation or 2) cooperativity between the two
pathways in AIR coronary arteries that is lost after DE inhalation. The combined
inhibition greatly blunted agonist induced dilation in both groups, suggesting there is
indeed cross-talk between these two pathways.
Interactions between NOS and COX products apparent in the current study have
been demonstrated previously in both cultured cells and isolated arteries (12; 93).
Products from each of the two pathways have been shown to negatively inhibit the
activity of the other, such that pharmacological blockade of one pathway alleviates the
inhibition of the other. The net result of NOS inhibition is thus masked by the increased
activity of the COX dilator pathway and vice versa. Therefore the concurrent inhibition
of NOS and COX blunts dilation more than the sum of inhibiting either pathway alone.
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The synergistic effect of combined inhibition of NOS and COX was seen in both AIR
and DE arteries which suggests the NOS/COX interaction is not lost after DE exposure
and plays an essential role in the regulation of coronary artery tone.
ACh-induced dilation was partially mediated by the activation of SK and IK
channels but does not appear to be altered by DE exposure. SK and IK channel inhibition
reduced dilation in both groups but dilation was still less in the DE compared to AIR
arteries. Potassium channel blockers induce membrane depolarization that decreases the
electrochemical driving force for Ca2+ entry into endothelial cells (23) potentially
reducing NOS and COX activation. Therefore, these data alone do not implicate a role of
SK and IK in ACh mediated dilation directly but because the combined inhibition of
NOS, COX, SK and IK abolished dilation, it appears each pathway is an important
contributor to ACh-mediated dilation.
Thus, parallel to the findings with ET-1, the diminished ACh-induced dilation in
DE arteries appears to be mediated by NOS dysfunction. Supporting the previous
speculation that DE inhalation leads to NOS uncoupling, sepiapterin supplementation
antagonized the effects of DE insinuating the dysfunction results from a loss of
endogenous BH4. Both physical and electrochemical coupling of NOS requires sufficient
cofactor bioavailability. DEP can generate an oxidative environment in a cellular system
(65) and it is plausible that the increase in oxidative stress depletes BH4 levels. NOS
derived O2·- further contributes to additional BH4 scavenging and further exacerbates
NOS and endothelial dysfunction (45; 60; 64).
Surprisingly, sepiapterin supplementation blunted endothelium dependent dilation
in AIR arteries compared to untreated arteries. Sepiapterin indirectly elevates BH4 levels
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by first releasing BH2, which

is subsequently converted to BH4 by dihydrofolate

reductase through the salvage pathway (88). Saturation of dihydrofolate reductase
activity shunts excess BH2 to competitively bind to NOS, mimicking BH4 depletion and
NOS uncoupling (18; 81). The effects of sepiapterin supplementation were NOS
dependent as L-NNA treatment prevented any changes in vascular reactivity of both
groups. Therefore, sepiapterin treatment appeares to have increased BH4 levels to restore
NOS function in DE-arteries while uncoupling NOS by elevating BH2 levels in AIRarteries.
Furthermore, BH4 levels are regulated by a balance between the de novo and
salvage pathways. Guanosine triphosphate cyclohydrolase I (GTPCH) is the rate limiting
enzyme in the synthesis of BH4 and is inhibited by lipid peroxidation products. One such
product, 4-hydroxy-2-nonenal (4-HNE), promotes the proteosomal degradation of
GTPCH (97). If DE exposure increases 4-HNE levels to decrease GTPCH and therefore
reduce BH4 availability, we would detect a decrease in GTPCH protein levels in
conjunction with lower BH4 levels. This may offer an alternative pathway by which DE
mediates a decrease in this essential cofactor and NOS uncoupling (95).
Scavenging O2·- with PEG-SOD restored agonist-mediated dilation in DE
coronary arteries without affecting dilation in AIR arteries. SOD catalyses the conversion
of O2·- to hydrogen peroxide, which has vasodilator properties (58) and may partially
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Figure 1. Biosynthesis of tetrahydrobiopterin (BH4). Dihydrobiopterin (BH2)
Guanosine-5'-triphosphate (GTP), GTP cyclohydrolase I (GTPCH), sepiapterin
reductase (SR), ONOO- (peroxynitrite), dihydrofolate reductase (DHFR).
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mediate the restoration of ACh-induced dilation. However, given that NOS inhibition,
BH4 supplementation and ROS scavenging restored endothelial function, we draw the
conclusion that DE inhalation uncouples NOS through increased ROS generation and not
loss of H2O2 production. It would be interesting to evaluate the combined effects of O2·scavenging and BH4 supplementation. If increased oxidative stress mediates NOS
uncoupling, scavenging ROS would prevent uncoupling and BH4 supplementation should
blunt ACh mediated dilation similar to sepiapterin treatment alone in AIR arteries. To
further evaluate our hypothesis that DE leads to NOS dysfunction, measurements of NO
levels in the presence of PEG-SOD or sepiapterin would show increased NO levels
compared to vehicle-treated DE arteries.
Although a single exposure to inhaled DE dramatically altered coronary artery
vasoreactivity, changes in cardiac parameters were not as apparent. Calculated SNSA
was not different between groups as there was withdrawal of both SNSA and PSNSA
over the 5 hour exposure period in both groups. Similarly, plasma NE was not different
between groups. Epidemiology studies of healthy participants further confirm the current
findings by demonstrating that cardiac parameters, either immediately or hours post
exposure, are not altered by exposure to air pollutants (20; 30). Furthermore, DE
exposure-induced decreases in brachial artery diameter occurred in the absence of plasma
catecholamine changes (69) indicating alterations in vascular reactivity can occur
independent of changes in overall autonomic and cardiac parameters.
Individuals with preexisting cardiovascular disease and other susceptible
conditions, however, do display changes in HRV after exposure to air pollutants. DE
inhalation decreased HRV with persistent ventricular arrhythmia following exposure in a
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chronic ischemic heart failure rat model (7). In the elderly population, decreased HRV
was exhibited following a elevated levels of air pollution (2). Interestingly, DEP instilled
into rat lungs decreased HRV with an associated increase in inflammatory factors.
However, inflammatory factors can augment SNSA and exacerbate changes in various
heart rate variability and other cardiac parameters (24; 41; 53; 92). Therefore preexisting
disease and local inflammation, absent in the current studies, appear to be requisite for
DE-induced activation of SNSA.
Normal circadian patterns presumably contributed to the fall in heart rate
observed in both AIR- and DE-exposed instrumented rats as the start of exposure
coincided with the onset of the normal sleep period (9). However, the concurrent fall in
MAP during the 5 hour period in the AIR rats was absent in DE-exposed rats. It is not
evident if the maintained MAP is SNSA or PSNSA driven as changes in LF and HF were
not different between groups. It is plausible that the differential MAP response results
from increased vascular resistance as mediated by enhanced vasoconstriction and
diminished vasodilation as observed in the cardiac (13; 15) and systemic vasculature (48)
of isolated arteries following DE exposure.
In summary, DE inhalation augmented coronary artery ET-1 constrictor
sensitivity and blunted ACh-mediated dilation through a NOS dependent pathway. Basal
levels of NOS generated O2·- are elevated following DE exposure and O2·- scavenging,
NOS inhibition or BH4 supplementation restored coronary function. Therefore our data
suggest DE mediates endothelial dysfunction by depletion of BH4 to uncouple NOS
(figure 2) without greatly altering hemodynamic parameters. Therefore, alterations in
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Figure 2. Mechanism of DE induced endothelial dysfunction of coronary arteries.
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coronary and systemic artery function appear to drive the greatest initial insult on the
vasculature which may not be apparent in healthy individuals..
Perspectives and Significance
Metabolic syndrome is characterized by a cluster of risk factors that include
elevated blood pressure, blood sugar, and plasma cholesterol and excess abdominal fat.
Individuals diagnosed with metabolic syndrome are at greater risk for cardiovascular
disease, stroke and diabetes (31; 32). Although air pollution exposure has been
demonstrated to negatively impact cardiac parameters and vascular function independent
of metabolic syndrome risk factors (68; 69), individuals with metabolic syndrome had a
potentiated risk for the negative effects of particulate air pollution exposure (67).
Populations with preexisting cardiovascular diseases, therefore, have greater risk of
mortality following exposure and individuals with ischemic heart disease represent the
most vulnerable subgroup for air pollution-related cardiovascular mortality (72). The
increase in the onset of myocardial infarction an hour after exposure (71) suggests an
immediate impairment of coronary artery function, possibly from a decrease of BH4
bioavailability as observed in the current studies. Therefore, due to the preexisting
impairment of coronary function, the subpopulation with CAD is at the greatest risk of
mortality as air pollutants may exacerbate narrowing of the arteries to cause myocardial
ischemia and infarction.
The progression of atherosclerosis is exacerbated by elevated levels of low
density lipoprotein (LDL) and oxidative stress associated with many cardiovascular
diseases (36). Formation of atherosclerotic plaques from the oxidation of LDL occludes
coronary arteries to advance the development of CAD. Occlusions of the coronaries
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decrease blood flow, reducing oxygen delivery to cardiac tissues. The increase in
vascular resistance found in various forms of hypertension (5) can exacerbate the effects
of CAD by increasing the workload of the heart and the demand for oxygen delivery.
Without the compensatory increase in coronary blood flow to match the oxygen
demands, chronic mild-to-moderate myocardial ischemia can result in progressive heart
failure. Patients with CAD are often treated with statins to lower cholesterol synthesis
and improve endothelial dysfunction by decreasing oxidative stress (19; 82). In addition
to its effects on cholesterol regulation, statins can attenuate ambient air pollution induced
inflammatory responses (77) which can slow the progression of atherosclerosis.
Furthermore, angiotensin-converting enzymes inhibitors are commonly used for
the treatment of hypertension and have been suggested to improve CAD patient outcome
by decreasing vascular resistance, blood pressure and improving endothelial function (26;
27). Lowering the level of angiotension II may also reduce the impact of air pollution
exposure by diminishing activation of NADPH oxidase to generate ROS, a source of
NOS uncoupling (19). Coronary artery function can also be improved by exogenous NO
treatment with nitroglyercin (85), a common treatment for angina pectoris. However, air
pollution induced oxidative stress can potentially counteract the beneficial effects of
nitroglyercin by scavenging NO and generating ONOO- to uncouple endogenous NOS.
Our studies suggest that supplementation with antioxidants to scavenge ROS would
improve the effectiveness of nitroglyercin following exposure to air pollution. Although
these pharmacological interventions help manage and lower the risk of CAD, population
studies still demonstrate an additional risk contributed from air pollution on
cardiovascular mortality suggesting that further interventions are needed.
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Based on the present studies, increasing biological levels of BH4 in conjunction
with current metabolic syndrome treatments may diminish the effects of air pollution on
the cardiovascular system. Acute supplementation of BH4 has been demonstrated to
improve vascular function in various cardiovascular diseases. Coronary blood flow was
improved in patients with CAD when BH4 was co-infused with ACh (80). Patients with
essential hypertension treated with BH4 showed restoration of forearm blood flow to
levels seen in normotensive controls (37). The beneficial effects of long term oral
administration of BH4 seen in patients with hypercholesterolemia may also protect from
exhaust-induced vascular dysfunction. After 4 weeks of treatment, plasma BH4 levels
were elevated and NO-mediated forearm blood flow was augmented and normalized
compared to healthy control subjects (16). Patients with uncontrolled hypertension on
traditional stable antihypertensive therapy saw significant reduction in MAP with 4
weeks of oral BH4 treatment. Brachial artery function was also improved with BH4
supplementation although the effects on MAP and vascular function was reversible upon
the cessation of the treatment (74).Currently, there are over half a dozen clinical trials in
the U.S. evaluating the effectiveness of a synthetic BH4, sapropterin dihydrochloride
(BioMarin Pharmaceutical), in patients with peripheral arterial disease, pulmonary
arterial hypertension and coronary artery disease (46).
In addition to the potential benefits of oral BH4 supplementation in subjects with
preexisting cardiovascular diseases, the current findings suggest oral supplementation of
BH4 might blunt the detrimental coronary artery vascular effects of air pollution. Clinical
studies with controlled exposures to diesel emissions in a manner similar to previous
reports (56; 57) could easily confirm the relevance of supplemental BH4 therapy.
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However, further investigations to address the effects of supplemental BH4 in healthy
individuals are needed, as the data from the current studies caution against BH4
“overload” as it may impair coronary artery function. Takeda and colleagues observed in
the absence of plasma BH4 level changes, elevated BH2 levels correlated with a decrease
in flow mediated dilation of the brachial artery. Consequently, an increase in BH4/BH2
ratio positively correlated with flow mediated dilation and endothelial function (84).
Therefore, additional clinical research is needed to determine the mechanisms of both the
beneficial and detrimental effects of BH4 supplementation.
DE constituents may be the initial source of the oxidative burst that leads to the
oxidation of BH4 to uncouple NOS, thereby initiating the feed forward cycle of
endothelial dysfunction. The increase in DE-induced ROS may oxidize BH4, potentially
hindering the beneficial effects of BH4 supplementation. In conjunction with BH4
supplementation, additional therapy with antioxidants should reduce air pollution
mediated ROS generation to help stabilize and prolong BH4 delivery to target organs.
Romieu et al. showed decreased antioxidant function with exposure to air pollution in the
elderly population of Mexico City (76). Omega-3 polyunsaturated fatty acid
supplementation improved endogenous SOD activity and increased levels of plasma GSH
thereby reducing air pollution induced oxidative stress. Increased dietary intake of
omega-3 polyunsaturated fatty acids has also been associated with improved HRV
parameters in the elderly (39). In hypercholesterolemia patients, acute infusion of vitamin
C augmented agonist induced endothelium dependent vasodilatation of the brachial artery
(89). Hornig et al. found oral administration of vitamin C for four weeks in patients with
chronic heart failure restored flow dependent dilation that was L-NMMA sensitive (40).
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These studies suggest endothelial dysfunction observed with metabolic syndromes are
associated with elevated oxidative stress which can be attenuated with antioxidant
treatment. However, it must be noted that long term follow up studies of vitamin
supplementation found that increased plasma vitamin levels exhibited no significant
reduction in mortality from cardiovascular disease (1).
More recently, we found that inhalation of comparable levels of exogenous NO
found in DE elevated plasma NOX and enhanced ET-1 constrictor responses (47)
paralleling the current findings with whole DE. In addition, depletion of BH4 levels by
oxidizing components in DE could contribute to exogenous NO induced uncoupling of
endogenous NOS (59). In an oxidative environment induced by DE inhalation,
exogenous NO may be transformed to ONOO- which then oxidizes and depletes the
available BH4. This would lead to uncoupled NOS and propagation of ROS generation
with resultant endothelial dysfunction. Therefore, increased antioxidant capacity may
also be useful in the reduction of exogenous NO oxidation. However, all of this is
conjectural and elucidation of the cell signaling changes initiated by air pollutants will
greatly increase our understanding of possible interactions of pollutants and their
products with both therapeutic medications and endogenous pathways that are altered by
other cardiovascular diseases.
Alternatively, the cardiovascular effects of DE inhalation may not be a direct
action of a constituent of DE (48; 52), but instead secondary to an inflammatory response
(90). ROS-independent impairment of NOS-mediated relaxation following PM exposure
has been shown to be reversed with anti-inflammatory drugs (17) implying effects are
secondary to inflammation. However, we found that plasma levels of cytokines typically
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associated with acute inflammation were not different between groups following DE
exposure. This is in agreement with previous observations that C-reactive protein does
not increase with DE exposure in healthy human subjects (14) corroborating our
observation that vascular parameters can be altered in the absence of pulmonary
inflammation.
Not surprisingly, the greatest impact in reducing air pollution related
cardiovascular mortality to date has been by reducing non-natural sources of PM. In the
mid 1960s, an 8.5 month copper smelter strike in 4 US Southwest states resulted in a 60%
decline of sulfate PM that was associated with a significant drop in mortality. Likewise,
the Harvard Six Cities study showed a strong association of air pollution with fine PM
and increased cardiopulmonary mortality for a 15 year period from the mid 1970 in six
(mid)eastern US cities (21). In an 8 year follow-up, the reduction in PM concentrations in
the six cities was also associated with a decrease in mortality risk (50). Across the US, an
examination of 51 metropolitan areas over 2 decade periods showed an increase, as much
as 15%, in life expectancy associated with a 10 µg/m3 reduction in PM (73). It should be
acknowledged that while PM was the indexed metric, there were correlated declines in
gaseous pollutants as well.
The US Environmental Protection Agency has implemented more stringent
standards for both new highway diesel engines and fuels and nonroad diesel fuels. The
reduction in diesel fuel sulfur (and therefore sulfur-containing emissions) allows the use
of aftertreatment technologies to further reduce DE related pollutants, especially PM.
However, other constituents of DE may remain relatively unchanged by these
interventions, and warrant further study into potential health effects. It is estimated motor
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vehicles account for half of nationwide NOX emissions and that diesel engines are
responsible for 50% of those emissions. NO is oxidized readily in the atmosphere and
promotes the synthesis of ozone. The cardiovascular effects of DE may thus be mediated
in part by NO directly (47; 59) or indirectly through ozone, which potentially has
adverse vascular effects (87; 96) and can potentiate the effects of DE (10; 44). Although
these proposed and existing aftertreatment processes will reduce harmful emissions, our
data suggest additional regulation of NOX products may be needed to truly mitigate the
public and environmental health impact of DE exposure.
Epidemiology studies show the subpopulation with metabolic syndrome is most
susceptible to the detrimental effects of air pollution exposure. Increases in oxidative
stress and inflammation are underlying pathways that mediate the effects of air pollution
on the cardiovascular system. Although standard-of-care pharmacological strategies to
control the progression of cardiovascular disease may overlap with these underlying
pathways affected by air pollution, our research suggests that exogenous BH4
supplementation could be a complementary therapeutic in this subpopulation. More
broadly, the general reduction of air pollution is still greatly beneficial to the immediate
improvement of public health. Identification of key chemical pollutants of vehicular
exhaust that are most harmful would guide advancements in aftertreatment technology
and improve environmental policies.

143

Reference List
1. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in
20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:
23-33, 2002.

2. Adar SD, Gold DR, Coull BA, Schwartz J, Stone PH and Suh H. Focused
exposures to airborne traffic particles and heart rate variability in the elderly.
Epidemiology 18: 95-103, 2007.

3. Alderton WK, Cooper CE and Knowles RG. Nitric oxide synthases: structure,
function and inhibition. Biochem J 357: 593-615, 2001.

4. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD and
Kanagy NL. Endothelin type A receptor antagonist normalizes blood pressure in
rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol
295: H434-H440, 2008.

5. Allahdadi KJ, Walker BR and Kanagy NL. Augmented endothelin
vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:
705-709, 2005.

6. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D,
Lieberman EH, Ganz P, Creager MA, Yeung AC and . Close relation of

144

endothelial function in the human coronary and peripheral circulations. J Am Coll
Cardiol 26: 1235-1241, 1995.

7. Anselme F, Loriot S, Henry JP, Dionnet F, Napoleoni JG, Thuillez C and
Morin JP. Inhalation of diluted diesel engine emission impacts heart rate
variability and arrhythmia occurrence in a rat model of chronic ischemic heart
failure. Arch Toxicol 81: 299-307, 2007.

8. Baulig A, Garlatti M, Bonvallot V, Marchand A, Barouki R, Marano F and
Baeza-Squiban A. Involvement of reactive oxygen species in the metabolic
pathways triggered by diesel exhaust particles in human airway epithelial cells.
Am J Physiol Lung Cell Mol Physiol 285: L671-L679, 2003.

9. Ben Dov IZ, Kark JD, Ben Ishay D, Mekler J, Ben Arie L and Bursztyn M.
Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med 167:
2116-2121, 2007.

10. Bosson J, Pourazar J, Forsberg B, Adelroth E, Sandstrom T and Blomberg
A. Ozone enhances the airway inflammation initiated by diesel exhaust. Respir
Med 101: 1140-1146, 2007.

11. Bouma P, Ferdinandy P, Sipkema P, Allaart CP and Westerhof N. Nitric
oxide is an important determinant of coronary flow in the isolated blood perfused
rat heart. Basic Res Cardiol 87: 570-584, 1992.

145

12. Bratz IN and Kanagy NL. Nitric oxide synthase-inhibition hypertension is
associated with altered endothelial cyclooxygenase function. Am J Physiol Heart
Circ Physiol 287: H2394-H2401, 2004.

13. Campen MJ, Babu NS, Helms GA, Pett S, Wernly J, Mehran R and
McDonald JD. Nonparticulate components of diesel exhaust promote
constriction in coronary arteries from ApoE-/- mice. Toxicol Sci 88: 95-102, 2005.

14. Carlsten C, Kaufman JD, Peretz A, Trenga CA, Sheppard L and Sullivan
JH. Coagulation markers in healthy human subjects exposed to diesel exhaust.
Thromb Res 120: 849-855, 2007.

15. Cherng TW, Campen MJ, Knuckles TL, Gonzalez BL and Kanagy NL.
Impairment of coronary endothelial cell ET(B) receptor function after short-term
inhalation exposure to whole diesel emissions. Am J Physiol Regul Integr Comp
Physiol 297: R640-R647, 2009.

16. Cosentino F, Hurlimann D, Delli GC, Chenevard R, Blau N, Alp NJ,
Channon KM, Eto M, Lerch P, Enseleit F, Ruschitzka F, Volpe M, Luscher
TF and Noll G. Chronic treatment with tetrahydrobiopterin reverses endothelial
dysfunction and oxidative stress in hypercholesterolaemia. Heart 94: 487-492,
2008.

146

17. Courtois A, Andujar P, Ladeiro Y, Baudrimont I, Delannoy E, Leblais V,
Begueret H, Galland MA, Brochard P, Marano F, Marthan R and Muller B.
Impairment of NO-dependent relaxation in intralobar pulmonary arteries:
comparison of urban particulate matter and manufactured nanoparticles. Environ
Health Perspect 116: 1294-1299, 2008.

18. Crabtree MJ, Smith CL, Lam G, Goligorsky MS and Gross SS. Ratio of
5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines
glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol
Heart Circ Physiol 294: H1530-H1540, 2008.

19. Cui W, Matsuno K, Iwata K, Ibi M, Katsuyama M, Kakehi T, Sasaki M,
Ikami K, Zhu K and Yabe-Nishimura C. NADPH oxidase isoforms and antihypertensive effects of atorvastatin demonstrated in two animal models. J
Pharmacol Sci 111: 260-268, 2009.

20. Devlin RB, Ghio AJ, Kehrl H, Sanders G and Cascio W. Elderly humans
exposed to concentrated air pollution particles have decreased heart rate
variability. Eur Respir J Suppl 40: 76s-80s, 2003.

21. Dockery DW, Pope CA, III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris
BG, Jr. and Speizer FE. An association between air pollution and mortality in
six U.S. cities. N Engl J Med 329: 1753-1759, 1993.

147

22. Evans NJ and Walker JW. Endothelin receptor dimers evaluated by FRET,
ligand binding, and calcium mobilization. Biophys J 95: 483-492, 2008.

23. Faraci FM and Heistad DD. Regulation of the cerebral circulation: role of
endothelium and potassium channels. Physiol Rev 78: 53-97, 1998.

24. Farraj AK, Hazari MS, Haykal-Coates N, Lamb C, Winsett DW, Ge Y,
Ledbetter AD, Carll AP, Bruno M, Ghio A and Costa DL. ST Depression,
Arrhythmia, Vagal Dominance, and Reduced Cardiac MicroRNA in Particulateexposed Rats. Am J Respir Cell Mol Biol 2010.

25. Feldstein C and Romero C. Role of endothelins in hypertension. Am J Ther 14:
147-153, 2007.

26. Ferrari R and Fox K. Insight into the mode of action of ACE inhibition in
coronary artery disease: the ultimate 'EUROPA' story. Drugs 69: 265-277, 2009.

27. Ferrari R, Guardigli G and Ceconi C. Secondary Prevention of CAD with ACE
Inhibitors: A Struggle Between Life and Death of the Endothelium. Cardiovasc
Drugs Ther 2010.

28. Filleul L, Rondeau V, Vandentorren S, Le Moual N, Cantagrel A, AnnesiMaesano I, Charpin D, Declercq C, Neukirch F, Paris C, Vervloet D,
Brochard P, Tessier JF, Kauffmann F and Baldi I. Twenty five year mortality

148

and air pollution: results from the French PAARC survey. Occup Environ Med
62: 453-460, 2005.

29. Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease:
uncoupling of oxygen reduction from NO synthesis and its pharmacological
reversal. Biol Chem 387: 1521-1533, 2006.

30. Frampton MW, Utell MJ, Zareba W, Oberdorster G, Cox C, Huang LS,
Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM and Stewart J.
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects
with asthma. Res Rep Health Eff Inst 1-47, 2004.

31. Galassi A, Reynolds K and He J. Metabolic syndrome and risk of cardiovascular
disease: a meta-analysis. Am J Med 119: 812-819, 2006.

32. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK and
Montori VM. Metabolic syndrome and risk of incident cardiovascular events and
death: a systematic review and meta-analysis of longitudinal studies. J Am Coll
Cardiol 49: 403-414, 2007.

33. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M,
Rosenthal W and Oksche A. Ligand-dependent differences in the internalization
of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279: 2767927687, 2004.

149

34. Haddy FJ, Vanhoutte PM and Feletou M. Role of potassium in regulating
blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol 290:
R546-R552, 2006.

35. Halcox JP, Nour KR, Zalos G and Quyyumi AA. Endogenous endothelin in
human coronary vascular function: differential contribution of endothelin receptor
types A and B. Hypertension 49: 1134-1141, 2007.

36. Higashi Y, Noma K, Yoshizumi M and Kihara Y. Endothelial function and
oxidative stress in cardiovascular diseases. Circ J 73: 411-418, 2009.

37. Higashi Y, Sasaki S, Nakagawa K, Fukuda Y, Matsuura H, Oshima T and
Chayama K. Tetrahydrobiopterin enhances forearm vascular response to
acetylcholine in both normotensive and hypertensive individuals. Am J Hypertens
15: 326-332, 2002.

38. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K and Marumo F.
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured
bovine endothelial cells. J Clin Invest 91: 1367-1373, 1993.

39. Holguin F, Tellez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernandez M
and Romieu I. Cardiac autonomic changes associated with fish oil vs soy oil
supplementation in the elderly. Chest 127: 1102-1107, 2005.

150

40. Hornig B, Arakawa N, Kohler C and Drexler H. Vitamin C improves
endothelial function of conduit arteries in patients with chronic heart failure.
Circulation 97: 363-368, 1998.

41. Huang CH, Lin LY, Tsai MS, Hsu CY, Chen HW, Wang TD, Chang WT,
Cheng TJ and Chen WJ. Acute cardiac dysfunction after short-term diesel
exhaust particles exposure. Toxicol Lett 192: 349-355, 2010.

42. Hynynen MM and Khalil RA. The vascular endothelin system in hypertension-recent patents and discoveries. Recent Patents Cardiovasc Drug Discov 1: 95108, 2006.

43. Ikeda M, Suzuki M, Watarai K, Sagai M and Tomita T. Impairment of
endothelium-dependent relaxation by diesel exhaust particles in rat thoracic aorta.
Jpn J Pharmacol 68: 183-189, 1995.

44. Kafoury RM and Kelley J. Ozone Enhances Diesel Exhaust Particles (DEP)Induced Interleukin-8 (IL-8) Gene Expression in Human Airway Epithelial Cells
through Activation of Nuclear Factors- kappaB (NF-kappaB) and IL-6 (NF-IL6).
Int J Environ Res Public Health 2: 403-410, 2005.

45. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a
role? Am J Physiol Heart Circ Physiol 281: H981-H986, 2001.

151

46. Katusic

ZS,

d'Uscio

LV

and

Nath

KA.

Vascular

protection

by

tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci
30: 48-54, 2009.

47. Knuckles TL, Buntz JG, Cherng TW, Lucas SN, Kanagy NL and Campen
MJ. Systemic Disposition and Vascular Effects of Inhaled Nitric Oxide. In
Preperation 2010.

48. Knuckles TL, Lund AK, Lucas SN and Campen MJ. Diesel exhaust exposure
enhances venoconstriction via uncoupling of eNOS. Toxicol Appl Pharmacol 230:
346-351, 2008.

49. Kumagai Y, Hayashi T, Miyauchi T, Endo A, Iguchi A, Kiriya-Sakai M,
Sakai S, Yuki K, Kikushima M and Shimojo N. Phenanthraquinone inhibits
eNOS activity and suppresses vasorelaxation. Am J Physiol Regul Integr Comp
Physiol 281: R25-R30, 2001.

50. Laden F, Schwartz J, Speizer FE and Dockery DW. Reduction in fine
particulate air pollution and mortality: Extended follow-up of the Harvard Six
Cities study. Am J Respir Crit Care Med 173: 667-672, 2006.

51. Langrish JP, Lundback M, Mills NL, Johnston NR, Webb DJ, Sandstrom T,
Blomberg A and Newby DE. Contribution of endothelin 1 to the vascular effects
of diesel exhaust inhalation in humans. Hypertension 54: 910-915, 2009.

152

52. Lund AK, Knuckles TL, Obot AC, Shohet R, McDonald JD, Gigliotti A,
Seagrave JC and Campen MJ. Gasoline exhaust emissions induce vascular
remodeling pathways involved in atherosclerosis. Toxicol Sci 95: 485-494, 2007.

53. Luttmann-Gibson H, Suh HH, Coull BA, Dockery DW, Sarnat SE, Schwartz
J, Stone PH and Gold DR. Systemic inflammation, heart rate variability and air
pollution in a cohort of senior adults. Occup Environ Med 2010.

54. McDonald JD, Barr EB and White RK. Design, Characterization, and
Evaluation of a Small-Scale Diesel Exhaust Exposure System. Aerosol Sci
Technol 38: 62-78, 2004.

55. Miller MR, Borthwick SJ, Shaw CA, McLean SG, McClure D, Mills NL,
Duffin R, Donaldson K, Megson IL, Hadoke PW and Newby DE. Direct
impairment of vascular function by diesel exhaust particulate through reduced
bioavailability of endothelium-derived nitric oxide induced by superoxide free
radicals. Environ Health Perspect 117: 611-616, 2009.

56. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S,
Boon NA, Donaldson K, Sandstrom T, Blomberg A and Newby DE. Ischemic
and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary
heart disease. N Engl J Med 357: 1075-1082, 2007.

153

57. Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, Macnee W,
Boon NA, Donaldson K, Blomberg A, Sandstrom T and Newby DE. Diesel
exhaust inhalation causes vascular dysfunction and impaired endogenous
fibrinolysis. Circulation 112: 3930-3936, 2005.

58. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M and Gutterman DD. Role for
hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ
Res 92: e31-e40, 2003.

59. Mochizuki S, Sipkema P, Goto M, Hiramatsu O, Nakamoto H, Toyota E,
Kajita T, Shigeto F, Yada T, Ogasawara Y and Kajiya F. Exogenous NO
suppresses flow-induced endothelium-derived NO production because of
depletion of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 288: H553H558, 2005.

60. Munzel T, Daiber A, Ullrich V and Mulsch A. Vascular consequences of
endothelial nitric oxide synthase uncoupling for the activity and expression of the
soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler
Thromb Vasc Biol 25: 1551-1557, 2005.

61. Muramatsu K, Numaguchi K, Egashira K, Takahashi T, Kasuya H and
Takeshita A. Effects of N-nitro-L-arginine on coronary artery tone and reactive

154

hyperemia after brief coronary occlusion in conscious dogs. Coron Artery Dis 5:
815-820, 1994.

62. Muto E, Hayashi T, Yamada K, Esaki T, Sagai M and Iguchi A. Endothelialconstitutive nitric oxide synthase exists in airways and diesel exhaust particles
inhibit the effect of nitric oxide. Life Sci 59: 1563-1570, 1996.

63. Nakamura S, Sugiyama S, Fujioka D, Kawabata K, Ogawa H and Kugiyama
K. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated
with impairment of nitric oxide-mediated coronary vasomotor function.
Circulation 108: 1425-1427, 2003.

64. Nurkiewicz TR, Wu G, Li P and Boegehold MA. Decreased arteriolar
tetrahydrobiopterin is linked to superoxide generation from nitric oxide synthase
in mice fed high salt. Microcirculation 17: 147-157, 2010.

65. Pan CJ, Schmitz DA, Cho AK, Froines J and Fukuto JM. Inherent redox
properties of diesel exhaust particles: catalysis of the generation of reactive
oxygen species by biological reductants. Toxicol Sci 81: 225-232, 2004.

66. Park S, Nam H, Chung N, Park JD and Lim Y. The role of iron in reactive
oxygen species generation from diesel exhaust particles. Toxicol In Vitro 20: 851857, 2006.

155

67. Park SK, Auchincloss AH, O'Neill MS, Prineas R, Correa JC, Keeler J, Barr
RG, Kaufman JD and Diez Roux AV. Particulate Air Pollution, Metabolic
Syndrome and Heart Rate Variability: the Multi-Ethnic Study of Atherosclerosis
(MESA). Environ Health Perspect 2010.

68. Peretz A, Kaufman JD, Trenga CA, Allen J, Carlsten C, Aulet MR, Adar SD
and Sullivan JH. Effects of diesel exhaust inhalation on heart rate variability in
human volunteers. Environ Res 107: 178-184, 2008.

69. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, Carlsten C,
Wilkinson CW, Gill EA and Kaufman JD. Diesel exhaust inhalation elicits
acute vasoconstriction in vivo. Environ Health Perspect 116: 937-942, 2008.

70. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, Baliff J,
Oh JA, Allen G, Monahan K and Dockery DW. Air pollution and incidence of
cardiac arrhythmia. Epidemiology 11: 11-17, 2000.

71. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE
and Lowel H. Exposure to traffic and the onset of myocardial infarction. N Engl J
Med 351: 1721-1730, 2004.

72. Pope CA, III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D and
Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air

156

pollution: epidemiological evidence of general pathophysiological pathways of
disease. Circulation 109: 71-77, 2004.

73. Pope CA, III, Ezzati M and Dockery DW. Fine-particulate air pollution and life
expectancy in the United States. N Engl J Med 360: 376-386, 2009.

74. Porkert M, Sher S, Reddy U, Cheema F, Niessner C, Kolm P, Jones DP,
Hooper C, Taylor WR, Harrison D and Quyyumi AA. Tetrahydrobiopterin: a
novel antihypertensive therapy. J Hum Hypertens 22: 401-407, 2008.

75. Roghair RD, Miller FJ, Jr., Scholz TD, Lamb FS and Segar JL. Coronary
constriction to angiotensin II is enhanced by endothelial superoxide production in
sheep programmed by dexamethasone. Pediatr Res 63: 370-374, 2008.

76. Romieu I, Garcia-Esteban R, Sunyer J, Rios C, Alcaraz-Zubeldia M, Velasco
SR and Holguin F. The effect of supplementation with omega-3 polyunsaturated
fatty acids on markers of oxidative stress in elderly exposed to PM(2.5). Environ
Health Perspect 116: 1237-1242, 2008.

77. Sakamoto N, Hayashi S, Mukae H, Vincent R, Hogg JC and van Eeden SF.
Effect of atorvastatin on PM10-induced cytokine production by human alveolar
macrophages and bronchial epithelial cells. Int J Toxicol 28: 17-23, 2009.

157

78. Schwartz J. Air pollution and hospital admissions for cardiovascular disease in
Tucson. Epidemiology 8: 371-377, 1997.

79. Schwartz J, Park SK, O'Neill MS, Vokonas PS, Sparrow D, Weiss S and
Kelsey K. Glutathione-S-transferase M1, obesity, statins, and autonomic effects
of particles: gene-by-drug-by-environment interaction. Am J Respir Crit Care
Med 172: 1529-1533, 2005.

80. Setoguchi S, Mohri M, Shimokawa H and Takeshita A. Tetrahydrobiopterin
improves endothelial dysfunction in coronary microcirculation in patients without
epicardial coronary artery disease. J Am Coll Cardiol 38: 493-498, 2001.

81. Sugiyama T, Levy BD and Michel T. Tetrahydrobiopterin recycling, a key
determinant of endothelial nitric-oxide synthase-dependent signaling pathways in
cultured vascular endothelial cells. J Biol Chem 284: 12691-12700, 2009.

82. Suh JW, Choi DJ, Chang HJ, Cho YS, Youn TJ, Chae IH, Kim KI, Kim CH,
Kim HS, Oh BH and Park YB. HMG-CoA reductase inhibitor improves
endothelial dysfunction in spontaneous hypertensive rats via down-regulation of
caveolin-1 and activation of endothelial nitric oxide synthase. J Korean Med Sci
25: 16-23, 2010.

83. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura
K, Ohsuzu F and Kurita A. Endothelium-dependent flow-mediated vasodilation

158

in coronary and brachial arteries in suspected coronary artery disease. Am J
Cardiol 82: 1535-1538, 1998.

84. Takeda M, Yamashita T, Shinohara M, Sasaki N, Takaya T, Nakajima K,
Inoue N, Masano T, Tawa H, Satomi-Kobayashi S, Toh R, Sugiyama D,
Nishimura K, Yokoyama M, Hirata K and Kawashima S. Plasma
tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial
dysfunction. Circ J 73: 955-962, 2009.

85. Takumi T, Yang EH, Mathew V, Rihal CS, Gulati R, Lerman LO and
Lerman A. Coronary endothelial dysfunction is associated with a reduction in
coronary artery compliance and an increase in wall shear stress. Heart 96: 773778, 2010.

86. Thomson E, Goegan P, Kumarathasan P and Vincent R. Air pollutants
increase gene expression of the vasoconstrictor endothelin-1 in the lungs. Biochim
Biophys Acta 1689: 75-82, 2004.

87. Thomson E, Kumarathasan P and Vincent R. Pulmonary expression of
preproET-1 and preproET-3 mRNAs is altered reciprocally in rats after inhalation
of air pollutants. Exp Biol Med (Maywood ) 231: 979-984, 2006.

88. Thony B, Auerbach G and Blau N. Tetrahydrobiopterin biosynthesis,
regeneration and functions. Biochem J 347 Pt 1: 1-16, 2000.

159

89. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P and Creager MA.
Vitamin C improves endothelium-dependent vasodilation in forearm resistance
vessels of humans with hypercholesterolemia. Circulation 95: 2617-2622, 1997.

90. Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL,
Macnee W, Donaldson K, Soderberg S, Newby DE, Sandstrom T and
Blomberg A. Persistent Endothelial Dysfunction Following Diesel Exhaust
Inhalation in Man. Am J Respir Crit Care Med 2007.

91. United States Environmental Protection Agency.2007 Frequently Asked Air
Questions [Online]. 2007.

92. Utell MJ, Frampton MW, Zareba W, Devlin RB and Cascio WE.
Cardiovascular effects associated with air pollution: potential mechanisms and
methods of testing. Inhal Toxicol 14: 1231-1247, 2002.

93. Vassalle C, Domenici C, Lubrano V and L'Abbate A. Interaction between
nitric oxide and cyclooxygenase pathways in endothelial cells. J Vasc Res 40:
491-499, 2003.

94. Vincent R, Kumarathasan P, Goegan P, Bjarnason SG, Guenette J, Berube
D, Adamson IY, Desjardins S, Burnett RT, Miller FJ and Battistini B.
Inhalation toxicology of urban ambient particulate matter: acute cardiovascular
effects in rats. Res Rep Health Eff Inst 5-54, 2001.

160

95. Wang S, Xu J, Song P, Wu Y, Zhang J, Chul CH and Zou MH. Acute
inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric
oxide synthase and elevates blood pressure. Hypertension 52: 484-490, 2008.

96. Watkinson WP, Campen MJ, Nolan JP and Costa DL. Cardiovascular and
systemic responses to inhaled pollutants in rodents: effects of ozone and
particulate matter. Environ Health Perspect 109 Suppl 4: 539-546, 2001.

97. Whitsett J, Picklo MJ, Sr. and Vasquez-Vivar J. 4-Hydroxy-2-nonenal
increases superoxide anion radical in endothelial cells via stimulated GTP
cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol 27:
2340-2347, 2007.

98. Witting PK, Rayner BS, Wu BJ, Ellis NA and Stocker R. Hydrogen peroxide
promotes endothelial dysfunction by stimulating multiple sources of superoxide
anion radical production and decreasing nitric oxide bioavailability. Cell Physiol
Biochem 20: 255-268, 2007.

161
APPENDIX
Specific Aim: Evaluate cardiac hemodynamic alterations during DE inhalation

Hypothesis: Acute inhalation of diesel engine exhaust augments heart rate and mean
arterial pressure and decreases heart rate variability.

Rationale: Numerous epidemiological studies have demonstrated higher risk for
cardiovascular mortality and morbidity with decreased air quality. It is estimated that on
and off road diesel engines contribute approximately 20% of U.S. ambient air pollution.
Cardiovascular changes in both human and animal models of DE exposure demonstrate
alterations in cardiovascular function and homeostasis. Air pollutant exposure of
susceptible animal models increases incidences of cardiac arrhythmias and ischemia
along with alterations in blood pressure and cardiac autonomic balance as measured by
heart rate variability. We therefore hypothesized that acute inhalation of DE augments
heart rate and mean arterial pressure and decreases heart rate variability in healthy
rodents. Additionally, augmented synthesis of endothelin following exposure has also
been documented. Since the release of endothelin can be regulated by autonomic outflow
we further investigated alterations in the endothelin system following exposure.

The manuscript is in preparation for submission to Cardiovascular Toxicology.
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Abstract
Multiple studies show associations between diesel exhaust (DE) exposure and
adverse cardiovascular sequelae. It has been proposed that inhaled pollutants can alter
autonomic nervous system function, as well as the endothelin (ET) signaling pathway.
We hypothesized DE inhalation elevates resting SNSA and ET vascular reactivity to
mediate vascular and hemodynamic responses to this air pollutant. Rats inhaled DE (300
µg particulate matter/m3) or AIR for 5 hours. Mean arterial pressure (MAP),
electrocardiograms (ECG) and heart rate (HR) were recorded prior to and throughout the
DE exposure using indwelling telemetry devices. Immediately following DE exposure,
rats were euthanized and tissues obtained to evaluate ET expression. ECG data were
analyzed to determine HR variability (HRV) as an index of sympathetic nervous system
activity (SNSA). Rats inhaling DE exhibited a slight rise in MAP compared to baseline,
while filtered air-exposed rats showed the typical circadian reduction of MAP. HRV
analysis did not show differences between exposure groups. ET-3 and ETA receptor, but
not ET-1 transcripts were increased in lungs from DE rats. In summary, elevated MAP
following DE exposure may increase cardiac work load whereas increased expression of
ET pathway components could diminish oxygen delivery. These data suggest that whole
DE inhalation could be a contributing factor in the cardiovascular mortality associated
with air pollution.
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Introduction
Multiple studies show associations between air pollution and the incidence of
cardiovascular mortality and morbidity in urban populations (2; 14; 35). Cardiac
arrhythmias, changes in blood pressure, and decreases in heart rate variability (HRV) are
observed with decrements in air quality or controlled exposures to particulate matter air
pollution in both humans and animal models (16; 27).

However, the effects are often

subtle and not always consistent, suggesting that several factors may play a role, from
individual susceptibility to the physicochemical nature of the pollutant mixture. Recent
evidence for near roadway exposures driving cardiovascular morbidity suggests that
vehicular engine emissions, in total, may have a more potent effect than PM, alone (2;
28). In an elderly population, concentrated ambient air pollution particles (CAPS) caused
a decrease in HRV (15) that was also observed with DE exposure(1). Vehicular emissions
appear to impact the urban population significantly (18; 22; 29; 36) and are an obvious
target to potentially improve health outcomes.
Of the sources of vehicular exhaust, diesel exhaust (DE) contributes significantly
to the particulate load in urban settings (7). Several emerging studies indicate that
specific components of DE acutely increase endothelin synthesis (25), endothelial
dysfunction (20; 24), oxidative stress (4; 5), and blood pressure (33). Previously, we
demonstrated coronary arteries from DE exposed rats displayed enhanced constriction to
ET-1 and diminished dilation to ACh that was NOS dependent (12). Additionally,
alterations in systemic arterial and venous function were also apparent following DE
exposure (24). We have also observed that whole DE exposure in spontaneously
hypertensive rats led to a persistent elevation in heart rate and increased AV nodal
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conduction duration that lasted several days after exposures ended (9). Similar findings
were observed in a model of chronic heart failure in rats where ventricular arrhythmias
were persistent even after cessation of exposure (3). However, the effects of short term
DE inhalation on cardiac parameters in healthy subjects are not clearly defined. We
hypothesized that whole DE inhalation would decrease HRV and elevate MAP in healthy
rodents.
Methods
Animals: Animal protocols for this study were approved by the Institutional
Animal Care and Use Committee of the Lovelace Respiratory Research Institute and
followed the National Institutes of Health guidelines for animal use in research. Male
Sprague Dawley and Fisher 344 (Charles River Laboratories, Reno, NV) rats weighing
250 to 300 g were used for all studies. Animals (n = 8 / group) were housed in chambers
with free access to food and water and exposed to either 5 hours of filtered AIR or DE
(300 µg/m3 PM). MAP, HR and ECG were recorded before and throughout the DE/AIR
exposure periods. Following the exposure, rats were deeply anesthetized with sodium
pentobarbital (150 mg/kg) and tissues collected. Tissues were immediately placed in
RNAlater (Ambion) overnight and stored at -80˚C.
Mean arterial pressure: Rats were instrumented with telemetry devices as
instructed by the manufacturer (Data Sciences Instruments, Minneapolis, MN) to record
mean arterial pressure (MAP), heart rate (HR) and electrocardiograms (ECG). After one
week recovery, rats were exposed to either filtered AIR or DE as described above.
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Heart rate variability analysis: RR interval (RRI, msec/beat), the time interval
between heart beats, was extracted from ECG recordings from radiotelemetery implanted
rats. RRI series was broken into 15 min intervals and transformed using custom software
as previously described (10). The low frequency (LF) variability range, representing a
composite of sympathetic nervous system activity (SNSA) and parasympathetic nervous
system activity (PSNSA), was set at 0.2–1.2 Hz, while the high frequency variability
(HF) range, representative of PSNSA, was set at 1.2–4.0 Hz. Sympathetic heart rate
variability, expressed as the ratio of LF/HF of transformed RR intervals, was used as an
index of SNSA. Heart rate (HR) was calculated from the recorded RRI (1 min/RRI = HR,
BPM) or from telemetry recordings.
Norepinephrine levels: Immediately after the 5 hour exposure, blood was
collected via cardiac puncture from anesthetized rats, chilled on ice, and centrifuged at
1000 rpm within 15 min of collection. Aliquots of plasma were frozen in liquid nitrogen
and stored at -80oC. Plasma norepinephrine (NE) levels were assessed using a
commercially available ELISA (BA 10-0200, Rocky Mountain Diagnostics, Inc).
mRNA analysis: Total RNA was extracted from coronary arteries using the RNeasy
Fibrous Tissue Mini Kit (Qiagen). Reverse transcription-generated cDNA (High Capacity
cDNA Reverse Transcription Kit, Applied Biosystems), and quantitative real-time
polymerase chain reaction (qRT-PCR) for ETAR, ETBR, ET-1, ET-3 and the endogenous
control 18s was performed using an Applied Biosystems’ Fast 7500 PCR machine and
TaqMan Gene Expression Assays. Data are expressed as relative change from AIR group.
Statistical analysis: mRNA transcripts level was expressed as a percent of AIR.
HR and HRV were expressed as actual values while MAP was expressed as a percent
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change from the hour prior to exposure. All data are expressed as means ± SEM. We
compared changes between groups using two-way analysis of variance and
p < 0.05 was considered statistically different.
Results
Heart rate variability: The effect of DE exposure on SNSA was estimated by
calculating the LF/HF ratio as described above. AIR exposure did not alter SNSA
compared to the hour prior to exposure. DE exposure also did not alter SNSA during the
5 hour exposure period nor was activity different from AIR (Figure 1). There was a drop
in both the LF and HF in both groups during the exposure period that was more
pronounced at specific time points in the DE-exposed rats than in the AIR-exposed
(Figures 2 and 3). There were no differences in plasma NE levels at the end of the 5 hour
exposure (Figure 6). The lack of change in LF/HF appears due to concomitant withdrawal
of both HF and LF power in both groups.
Heart rate: In both groups, HR decreased from the pre-exposure to exposure
period due to the normal morning circadian pattern. HR was not different between groups
prior to exposure. HR dropped the greatest in the first two hours in both groups. Both
groups displayed a reduction in HR that was sustained for the duration of exposure. The
reduction in HR was significantly greater in the DE exposed animals compared to the
AIR during the 2nd and 3rd hour of exposure (Figure 4).
Mean arterial pressure: MAP was greater in the DE group prior to the start of
exposure. AIR animals displayed a slight fall in blood pressure during the five hour
exposure compared to the hour prior to exposure. However, animals exposed to DE did
not have a similar fall in MAP throughout the five hour period (Figure 5) but maintained
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Figure 1: LF/HF from rats exposed to AIR or DE. Compared to the hour prior, animals
exposed to either AIR or DE did not have HRV alterations.
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Figure 2: Low frequency component of HRV from rats exposed to AIR or DE. Both
groups showed an equal decrease in LF power during the five hour exposure compared
to the hour prior. * < 0.05 compared to hour prior within group. # <0.05 compared
between groups.
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Figure 3: High frequency component of HRV from rats exposed to AIR or DE. Both
groups showed an equal decrease in HF power by the end of exposure compared to the
hour prior. DE animals tend to show greater parasympathetic withdraw compare to the
AIR. * < 0.05 compared to hour prior within group. # <0.05 compared between groups.
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Figure 4: Heart rate showed an equal fall in both groups during the exposure period. * <
0.05 compared to hour prior within group. # <0.05 compared between groups.
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Figure 5: DE exposure prevented fall in mean arterial pressure. DE animals had an
elevated MAP prior to the start of exposure and maintained the elevated pressure. * <
0.05 compared to hour prior within group. # <0.05 compared between groups.
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higher MAP compared to AIR. Thus there was a significant difference between AIR and
DE rats throughout the five hours of exposure.
Endothelin system mRNA transcripts: ET-1 transcripts were not different between
groups from lung, aorta or renal tissue (Figure 6). DE exposure elevated ET-3 message in
lung tissue but not in renal tissue compared to AIR. ETAR transcripts were elevated in
lung, but not aorta. ETAR tended to be elevated in the renal medulla but not in the cortex.
Discussion
In the present study we investigated HRV and hemodynamic alterations following
inhalation to DE. We observed that, in healthy rats, acute DE exposure had little acute
effect on HRV and MAP, consistent with these systems being under tight homeostatic
control. However, the subtle effects of DE were consistent with a disruption in circadian
control of the autonomic influence of HRV and MAP, which may be augmented by
certain conditions such as hypertension, sleep-disorderd breathing, or metabolic
syndrome. We also found that DE augments the various components of the endothelin
system, which may contribute to longer term effects on coronary reactivity and cardiac
morbidity.
Numerous epidemiology studies report increased cardiopulmonary mortality rates
proportional to pollution levels. We have previously shown that coronary arteries from
rats exposed to DE for 5 hours have increased ET-1 sensitivity (12) and diminished AChmediated dilation (13) that was endothelial NOS-dependent. Endothelial dysfunction can
be rescued by NOS inhibition or supplementation of necessary cofactors. Diminished
NOS production of NO in coronary arteries would narrow the coronary arteries to
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Figure 6: Plasma NE levels were not different between groups. ET-1, ET-3 and ETAR
transcripts were altered by DE exposure in aorta, renal medulla and renal cortex tissue.
ET-3 and ETAR were elevated but not ET-1 mRNA in lung tissue following acute
exposure to DE. * p < 0.05 compared between groups.
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decrease blood flow to the heart. Cardiac ischemia in turn could contribute to the increase
in cardiovascular related mortality with decreases in air quality level.
Animals from both groups displayed a fall in LF and HF indicating both SNSA
and PSNSA decrease at the onset of the sleep period even in the presence of DE
inhalation. Thus the calculated SNSA was not different between groups prior to or
during the 5 hours of DE exposure. DE-exposed animals tended to have a greater
parasympathetic withdrawal compared to AIR animals as calculated by the HRV data,
which correlated with HR changes during the first hour of exposures, where DE-exposed
rats exhibited a delayed onset of circadian HR reductions.

Beyond that timepoint,

however, HR tended to decrease more in the DE rats than the AIR rats. In agreement with
this observation, plasma NE, drawn at the end of the exposures, was not different
between groups. These data are in agreement with studies of healthy individuals who do
not have altered cardiac parameters either immediately or 24 hour after exposure to
concentrated ambient air pollution particles (15). Similarly healthy volunteers exposed to
ultrafine carbon particles at rest did not have measurable differences in cardiac
parameters (17). Therefore it appears that exposure to multiple air pollutants does not
cause acute cardiac dysfunction in the absence of pre-existing heart disease.
In contrast to several previous reports (1; 3; 11; 26), we did not find dramatic
changes in HRV after exposure to air pollutants. DE inhalation caused a more profound
withdrawal of both HF and LF power, but this was significant compared to the filtered
air-exposed rats at only a few time points. In a rat model of chronic ischemic heart
failure, DE inhalation decreased HRV during the exposure period with persistent
ventricular arrhythmia following exposure (3). We have also previously shown that
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spontaneously hypertensive rats exposed to DE exhibit mild but consistent changes in
ventricular conduction, in terms of PR intervals (9). Decreased HRV is also apparent in
the elderly population following increases in air pollution levels, primarily from
parasympathetic withdrawal (1). Additionally, Huang et. al recently reported that rats
instilled with DE particles (DEP) in the lungs had decreased HRV primarily from
increased HF and not LF decreases (i.e. more SNSA without PSMSA withdrawal) (23).
Along with decreased HRV, instillation of DEP also increased levels of inflammatory
factors which have been shown to augment SNSA (34) through increased NADPH
oxidase generation of reactive oxygen species (37). We previously reported that inhaled
DE in healthy rats does not detectably induce circulating inflammatory factors (12).
Therefore preexisting disease and local inflammation in response to direct installation of
DEP appear to be requisite for DE-induced activation of SNSA.
In agreement with subtle changes in HRV, heart rate fell similarly in both groups
during the exposure paradigm, with the exception of the first hour of exposures. This fall
in heart rate is due to the normal circadian pattern, as the start of the DE exposure period
coincided with the onset of the normal sleep period (6). Similarly, a matching decline in
MAP was observed during the 5 hour period in the air-exposed rats. However, the
expected fall in MAP was not observed in the rats exposed to DE. The lack of change in
LF and HF suggests the prevention of MAP dipping is not overtly SNSA or PSNA
driven. Alternatively, our previous report that acute DE inhalation uncouples NOS to
enhance vasoconstriction and diminish vasodilation in the cardiac (12) and systemic
vasculature (24) is consistent with elevated vascular resistance leading to the differential
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MAP response. Augmented constriction in systemic resistance vessels may therefore
contribute to the relatively elevated MAP.
In order to investigate a potential activation of the endothelin system, we
examined transcripts from this system in lungs, aorta and kidneys from AIR and DE
exposed rats. There were no detectable changes in ET-1 transcripts in the four tissue
targets immediately after exposure, in agreement with the previous findings that plasma
ET-1 levels are not acutely altered by DE (12). It has been shown that higher exposure
levels of particles (32) or collection of tissue at later time points (31) does reveal DEinduced generation of endothelin.
In contrast to the ET findings, ETAR and ET-3 mRNA were both elevated in lung
tissue by DE exposure. Greater endothelin receptor expression in the lung potentially
increases vascular resistance to elevate pulmonary arterial pressure resulting in right
ventricular hypertrophy. Unlike activation of the ETAR, activation of the ETBR primarily
mediates vasodilation through activation of eNOS (21) ET-3 is a somewhat selective
endogenous ligand for the ETBR and the elevation in ET-3 transcript could indicate
greater activation of the uncoupled endothelial NOS pathway.

We have previously

shown that activation of this system in coronary arteries enhances vasoconstriction (12)
and this effect may also contribute to the loss of the diurnal fall in MAP. Recent findings
by Brook et al showed that ambient particulates could induce a modest increased in
diastolic BP that was non-significantly attenuated by treatment with a general ET-1
receptor antagonist, Bosentan (8). The mild effects observed in that study are consistent
with our findings, and suggest that ET-1 has either a partial role in driving cardiovascular
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effects of air pollution or there are vulnerable subpopulations in which this pathway may
be more active than in others.
Overall, acute inhalation of diesel emissions did not result in large HRV or
hemodynamic changes, likely due to the overall health of the animal model. As reported
by many epidemiologic studies, the populations at the highest risk for coronary events are
the elderly and those with preexisting cardiovascular diseases. Therefore, rapid change in
vascular function with short term exposure to pollutants may provide an explanation for
the spike in hospital admission for various cardiac conditions while chronic elevations in
air pollution and prolonged exposure maybe required to alter cardiac parameters enough
in healthy individuals to result in heart failure (19; 30).
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